All Publications

  • Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation

    Authors: Wu Y., Chou T., Young L., Hsieh F., Pan H., Mo S., Brown S. B., Chen R., Kimchi A. & Lai M. (2020), Cell Death & Disease. 11, 305
  • Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma

    Authors: Kalaora S., Lee J. S., Barnea E., Levy R., Greenberg P., Alon M., Yagel G., Bar Eli G., Oren R., Peri A., Patkar S., Bitton L., Rosenberg S. A., Lotem M., Levin Y., Admon A., Ruppin E. & Samuels Y. (2020), Nature Communications. 11, 1, 896
  • Predicting and affecting response to cancer therapy based on pathway-level biomarkers

    Authors: Ben-Hamo R., Berger A. J., Gavert N., Miller M., Pines G., Oren R., Pikarsky E., Benes C. H., Neuman T., Zwang Y., Efroni S., Getz G. & Straussman R. (2020), Nature Communications. 11, 1, 3296
  • A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanoma

    Authors: Nagler A., Vredevoogd D. W., Alon M., Cheng P. F., Trabish S., Kalaora S., Arafeh R., Goldin V., Levesque M. P., Peeper D. S. & Samuels Y. (2020), Pigment Cell and Melanoma Research. 33, 2, p. 334-344
  • Mitochondrial carrier homolog 2 is necessary for AML survival

    Authors: Khan D. H., Mullokandov M., Wu Y., Voisin V., Gronda M. V., Hurren R., Wang X., MacLean N., Jeyaraju D. V., Jitkova Y., Xu G. W., Laister R. C., Seneviratne A., Blatman Z., Ketala T., Bader G. D., Marhon S. A., Carvalho D. D. D., Minden M. D., Gross A. & Schimmer A. D. (2020), Blood. 136, 1, p. 81-92
  • A framework for advancing our understanding of cancer-associated fibroblasts

    Authors: Sahai E., Astsaturov I., Cukierman E., DeNardo D. G., Egeblad M., Evans R. M., Fearon D., Greten F. R., Hingorani S. R., Hunter T., Hynes R. O., Jain R. K., Janowitz T., Jorgensen C., Kimmelman A. C., Kolonin M. G., Maki R. G., Powers R. S., Pure E., Ramirez D. C., Scherz-Shouval R., Sherman M. H., Stewart S., Tlsty T. D., Tuveson D. A., Watt F. M., Weaver V., Weeraratna A. T. & Werb Z. (2020), Nature Reviews Cancer. 20, 3, p. 174-186
  • A single-cell landscape of high-grade serous ovarian cancer

    Authors: Izar B., Tirosh I., Stover E. H., Wakiro I., Cuoco M. S., Alter I., Rodman C., Leeson R., Su M., Shah P., Iwanicki M., Walker S. R., Kanodia A., Melms J. C., Mei S., Lin J., Porter C. B. M., Slyper M., Waldman J., Jerby-Arnon L., Ashenberg O., Brinker T. J., Mills C., Rogava M., Vigneau S., Sorger P. K., Garraway L. A., Konstantinopoulos P. A., Liu J. F., Matulonis U., Johnson B. E., Rozenblatt-Rosen O., Rotem A. & Regev A. (2020), Nature Medicine.
  • Rational design of universal immunotherapy for TfR1-tropic arenaviruses

    Authors: Cohen-Dvashi H., Amon R., Agans K. N., Cross R. W., Borenstein-Katz A., Mateo M., Baize S., Padler-Karavani V., Geisbert T. W. & Diskin R. (2020), Nature Communications. 11, 1, 67
  • Immune related proteins and tumor infiltrating CD8+lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome

    Authors: Landin D., Ahrlund-Richter A., Mirzaie L., Mints M., Nasman A., Kolev A., Marklund L., Dalianis T., Munck-Wikland E. & Ramqvist T. (2020), Head and Neck.
  • Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts

    Authors: Kim K., Hu W., Audenet F., Almassi N., Hanrahan A. J., Murray K., Bagrodia A., Wong N., Clinton T. N., Dason S., Mohan V., Jebiwott S., Nagar K., Gao J., Penson A., Hughes C., Gordon B., Chen Z., Dong Y., Watson P. A., Alvim R., Elzein A., Gao S. P., Cocco E., Santin A. D., Ostrovnaya I., Hsieh J. J., Sagi I., Pietzak E. J., Hakimi A. A., Rosenberg J. E., Iyer G., Vargas H. A., Scaltriti M., Al-Ahmadie H., Solit D. B. & Coleman J. A. (2020), Nature Communications. 11, 1, 1975
  • Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations

    Authors: Goldstein E., Yeghiazaryan K., Ahmad A., Giordano F. A., Froehlich H. & Golubnitschaja O. (2020), EPMA Journal. 11, 3, p. 505-515
  • Single-cell analysis of clonal maintenance of transcriptional and epigenetic states in cancer cells

    Authors: Meir Z., Mukamel Z., Chomsky E., Lifshitz A. & Tanay A. (2020), Nature Genetics. 52, 7, p. 709-718
  • The Glioma Stem Cell Model in the Era of Single-Cell Genomics

    Authors: Suva M. L. & Tirosh I. (2020), Cancer Cell. 37, 5, p. 630-636
  • Inter-Tumor Heterogeneity-Melanomas Respond Differently to GM-CSF-Mediated Activation

    Authors: Moshe A., Izraely S., Sagi-Assif O., Malka S., Ben-Menachem S., Meshel T., Pasmanik-Chor M., Hoon D. S. & Witz I. P. (2020), Cells. 9, 7, 1683
  • Nanobodies Targeting Prostate-specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer

    Authors: Rosenfeld L., Sananes A., Zur Y., Cohen S., Dhara K., Gelkop S., Ben Zeev E., Shahar A., Lobel L., Akabayov B., Arbely E. & Papo N. (2020), Journal of Medicinal Chemistry. 63, 14, p. 7601-7615
  • Emerging roles of ECM remodeling processes in cancer

    Authors: Mohan V., Das A. & Sagi I. (2020), Seminars in Cancer Biology. 62, p. 192-200
  • Cardiac remodeling secondary to chronic volume overload is attenuated by a novel MMP9/2 blocking antibody

    Authors: Cohen L., Sagi I., Bigelman E., Solomonov I., Aloshin A., Ben-Shoshan J., Rozenbaum Z., Keren G. & Entin-Meer M. (2020), PLoS One. 15, 4, 0231202
  • Immunological Features of Non-neuronal Brain Cells: Implications for Alzheimer's Disease Immunotherapy

    Authors: Castellani G. & Schwartz M. (2020), Trends in Immunology. 41, 9, p. 794-804
  • The human tumor microbiome is composed of tumor type-specific intracellular bacteria

    Authors: Nejman D., Livyatan I., Fuks G., Gavert N., Zwang Y., Geller L. T., Rotter-Maskowitz A., Weiser R., Mallel G., Gigi E., Meltser A., Douglas G. M., Kamer I., Gopalakrishnan V., Dadosh T., Levin-Zaidman S., Avnet S., Atlan T., Cooper Z. A., Arora R., Cogdill A. P., Khan M. A. W., Ologun G., Bussi Y., Weinberger A., Lotan-Pompan M., Golani O., Perry G., Rokah M., Bahar-Shany K., Rozeman E. A., Blank C. U., Ronai A., Shaoul R., Amit A., Dorfman T., Kremer R., Cohen Z. R., Harnof S., Siegal T., Yehuda-Shnaidman E., Gal-Yam E. N., Shapira H., Baldini N., Langille M. G. I., Ben-Nun A., Kaufman B., Nissan A., Golan T., Dadiani M., Levanon K., Bar J., Yust-Katz S., Barshack I., Peeper D. S., Raz D. J., Segal E., Wargo J. A., Sandbank J., Shental N. & Straussman R. (2020), Science. 368, 6494, p. 973-980
  • Diffusion-weighted breast MRI of malignancies with submillimeter resolution and immunity to artifacts by spatiotemporal encoding at 3T

    Authors: Solomon E., Liberman G., Nissan N., Furman-Haran E., Sklair-Levy M. & Frydman L. (2020), Magnetic Resonance in Medicine.
  • The ECM path of senescence in aging: components and modifiers

    Authors: Levi N., Papismadov N., Solomonov I., Sagi I. & Krizhanovsky V. (2020), The FEBS journal.
  • Lipid Transfer Proteins and Membrane Contact Sites in Human Cancer

    Authors: Peretti D., Kim S., Tufi R. & Lev S. (2020), Frontiers in Cell and Developmental Biology. 7, 371
  • Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia

    Authors: Mathew N. R., Vinnakota J. M., Apostolova P., Erny D., Hamarsheh S., Andrieux G., Kim J., Hanke K., Goldmann T., Chappell-Maor L., El-Khawanky N., Ihorst G., Schmidt D., Duyster J., Finke J., Blank T., Boerries M., Blazar B. R., Jung S., Prinz M. & Zeiser R. (2020), The Journal of Clinical Investigation. 130, 3, p. 1315-1329
  • A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer's Disease

    Authors: Schwartz M., Ramos J. M. P. & Ben-Yehuda H. (2020), Journal of Immunology. 204, 2, p. 243-250
  • Intravital imaging of vascular anomalies and extracellular matrix remodeling in orthotopic pancreatic tumors

    Authors: Bochner F., Mohan V., Zinger A., Golani O., Schroeder A., Sagi I. & Neeman M. (2020), International Journal of Cancer. 146, 8, p. 2209-2217
  • The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic

    Authors: Kadosh E., Snir-Alkalay I., Venkatachalam A., May S., Lasry A., Elyada E., Zinger A., Shaham M., Vaalani G., Mernberger M., Stiewe T., Pikarsky E., Oren M. & Ben-Neriah Y. (2020), Nature.
  • Introducing PIONEER: a project to harness big data in prostate cancer research

    Authors: , Omar M. I., Roobol M. J., Ribal M. J., Abbott T. & Lancet D. (2020), Nature Reviews Urology. 17, 6, p. 351-361
  • Nasopharyngeal carcinoma joins the single-cell party

    Authors: Mints M. & Tirosh I. (2020), Cancer Communications. 40, 9, p. 453-455
  • Characterization of the human tumor microbiome reveals tumor-type specific intra-cellular bacteria

    Authors: Livyatan I., Nejman D., Shental N. & Straussman R. (2020), OncoImmunology. 9, 1, 1800957
  • Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features

    Authors: Benor G., Fuks G., Chin S., Rueda O., Mukherjee S., Arandkar S., Aylon Y., Caldas C., Domany E. & Oren M. (2020), BioRxiv.
  • Mapping cell phenotypes in breast cancer

    Authors: Keren L. & Angelo M. (2020), Nature Reviews Cancer. 1, 2, p. 156-157
  • Metabolic alterations in the tumor microenvironment and their role in oncogenesis

    Authors: Eisenberg L., Eisenberg-Bord M., Eisenberg-Lerner A. & Sagi-Eisenberg R. (2020), Cancer Letters. 484, p. 65-71
  • Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma

    Authors: Mur E. B., Bernardo S., Papon L., Mancini M., Fabbrizio E., Goussard M., Ferrer I., Giry A., Quantin X., Pujol J., Calvayrac O., Moll H. P., Glasson Y., Pirot N., Turtoi A., Canamero M., Wong K., Yarden Y., Casanova E., Soria J., Colinge J., Siebel C. W., Mazieres J., Favre G., Paz-Ares L. & Maraver A. (2020), Journal of Clinical Investigation. 130, 2, p. 612-624
  • Transcriptional profiling reveals a subset of human breast tumors that retain wtTP53but display mutant p53-associated features

    Authors: Benor G., Fuks G., Chin S., Rueda O. M., Mukherjee S., Arandkar S., Aylon Y., Caldas C., Domany E. & Oren M. (2020), Molecular Oncology.
  • Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer

    Authors: Katzenelenbogen Y., Sheban F., Yalin A., Yofe I., Svetlichnyy D., Jaitin D. A., Bornstein C., Moshe A., Keren-Shaul H., Cohen M., Wang S., Li B., David E., Salame T., Weiner A. & Amit I. (2020), Cell. 182, 4, p. 872-885
  • The Animal Lectin Galectin-8 Promotes Cytokine Expression and Metastatic Tumor Growth in Mice

    Authors: Shatz-Azoulay H., Vinik Y., Isaac R., Kohler U., Lev S. & Zick Y. (2020), Scientific Reports. 10, 1, 7375
  • HSF1 and Molecular Chaperones in Biology and Cancer

    Authors: Mendillo M. L., Pincus D. & Scherz-Shouval R. (2020),
  • Novel Proteome Extraction Method Illustrates a Conserved Immunological Signature of MSI-H Colorectal Tumors.

    Authors: Vainer E. D., Kania-Almog J., Zatara G., Levin Y. & Vainer G. W. (2020), Molecular & Cellular Proteomics.
  • Tumour heterogeneity and the evolutionary trade-offs of cancer

    Authors: Hausser J. & Alon U. (2020), Nature Reviews Cancer.
  • Efficient targeted degradation via reversible and irreversible covalent PROTACs

    Authors: Gabizon R., Shraga A., Gehrtz P., Livnah E., Shorer Y., Gurwicz N., Avram L., Unger T., Aharoni H., Albeck S., Brandis A., Shulman Z., Katz B., Herishanu Y. & London N. (2020), Journal of the American Chemical Society. 142, 27, p. 11734-11742
  • Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

    Authors: Chen Y., Yin J., Li W., Li H., Chen D., Zhang C., Lv J., Wang Y., Li X., Li J., Zhang P., Li Y., He Q., Yang X., Lei Y., Tang L., Zhou G., Mao Y., Wei C., Xiong K., Zhang H., Zhu S., Hou Y., Sun Y., Dean M., Amit I., Wu K., Kuang D., Li G., Liu N. & Ma J. (2020), Cell Research.
  • Fluorescent Silica Nanoparticles to Label Metastatic Tumor Cells in Mineralized Bone Microenvironments

    Authors: Chiou A. E., Hinckley J. A., Khaitan R., Varsano N., Wang J., Malarkey H. F., Hernandez C. J., Williams R. M., Estroff L. A., Weiner S., Addadi L., Wiesner U. B. & Fischbach C. (2020), Small. 2001432
  • Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner

    Authors: Barak A. F., Lewinsky H., Perpinial M., Huber V., Radomir L., Kramer M. P., Sever L., Wolf Y., Shapiro M., Herishanu Y., Jung S., Becker-Herman S. & Shachar I. (2020), Oncogene. 39, 9, p. 1997-2008
  • Hitting KRAS When It’s Down

    Authors: Gabizon R. & London N. (2020), Journal of Medicinal Chemistry. 63, 13, p. 6677-6678
  • Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis

  • Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression

    Authors: Parhi L., Alon-Maimon T., Sol A., Nejman D., Shhadeh A., Fainsod-Levi T., Yajuk O., Isaacson B., Abed J., Maalouf N., Nissan A., Sandbank J., Yehuda-Shnaidman E., Ponath F., Vogel J., Mandelboim O., Granot Z., Straussman R. & Bachrach G. (2020), Nature Communications. 11, 1, 3259
  • The Role of HSF1 and the Chaperone Network in the Tumor Microenvironment

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Authors: Hoshino A., Kim H. S., Bojmar L., Gyan K. E., Cioffi M., Hernandez J., Zambirinis C. P., Rodrigues G., Molina H., Heissel S., Mark M. T., Steiner L., Benito-Martin A., Lucotti S., Di Giannatale A., Offer K., Nakajima M., Williams C., Nogués L., Pelissier Vatter F. A., Hashimoto A., Davies A. E., Freitas D., Kenific C. M., Ararso Y., Buehring W., Lauritzen P., Ogitani Y., Sugiura K., Takahashi N., Alečković M., Bailey K. A., Jolissant J. S., Wang H., Harris A., Schaeffer L. M., García-Santos G., Posner Z., Balachandran V. P., Khakoo Y., Raju G. P., Scherz A., Sagi I., Scherz-Shouval R., Yarden Y., Oren M., Malladi M., Petriccione M., De Braganca K. C., Donzelli M., Fischer C., Vitolano S., Wright G. P., Ganshaw L., Marrano M., Ahmed A., DeStefano J., Danzer E., Roehrl M. H. A., Lacayo N. J., Vincent T. C., Weiser M. R., Brady M. S., Meyers P. A., Wexler L. H., Ambati S. R., Chou A. J., Slotkin E. K., Modak S., Roberts S. S., Basu E. M., Diolaiti D., Krantz B. A., Cardoso F., Simpson A. L., Berger M., Rudin C. M., Simeone D. M., Jain M., Ghajar C. M., Batra S. K., Stanger B. Z., Bui J., Brown K. A., Rajasekhar V. K., Healey J. H., de Sousa M., Kramer K., Sheth S., Baisch J., Pascual V., Heaton T. E., La Quaglia M. P., Pisapia D. J., Schwartz R., Zhang H., Liu Y., Shukla A., Blavier L., DeClerck Y. A., LaBarge M., Bissell M. J., Caffrey T. C., Grandgenett P. M., Hollingsworth M. A., Bromberg J., Costa-Silva B., Peinado H., Kang Y., Garcia B. A., O'Reilly E. M., Kelsen D., Trippett T. M., Jones D. R., Matei I. R., Jarnagin W. R. & Lyden D. (2020), Cell. 182, 4, p. 1044-1061
  • Tackling the Many Facets of Glioblastoma Heterogeneity

    Authors: Tirosh I. & Suva M. L. (2020), Cell Stem Cell. 26, 3, p. 303-304
  • Recent insights into the role of L1CAM in cancer initiation and progression

    Authors: Altevogt P., Ben-Ze'ev A., Gavert N., Schumacher U., Schäfer H. & Sebens S. (2020), International Journal of Cancer.
  • BACH family members regulate angiogenesis and lymphangiogenesis by modulating VEGFC expression

    Authors: Cohen B., Tempelhof H., Raz T., Oren R., Nicenboim J., Bochner F., Even R., Jelinski A., Eilam R., Ben-Dor S., Adaddi Y., Golani O., Lazar S., Yaniv K. & Neeman M. (2020), Life Science Alliance. 3, 4, 202000666
  • miR-17-92 and miR-106b-25 clusters regulate beta cell mitotic checkpoint and insulin secretion in mice

    Authors: Mandelbaum A. D., Kredo-Russo S., Aronowitz D., Myers N., Yanowski E., Klochendler A., Swisa A., Dor Y. & Hornstein E. (2019), Diabetologia. 62, 9, p. 1653-1666
  • Cooperativity between stromal cytokines drives the invasive migration of human breast cancer cells

    Authors: Elisha Y., Sagi Y., Klein G., Straussman R. & Geiger B. (2019), Philosophical Transactions of the Royal Society B: Biological Sciences. 374, 1779, 20180231
  • Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells (Scientific Reports, (2017), 7, 1, (16345), 10.1038/s41598-017-16558-0)

    Authors: Arafeh R., Flores K., Keren-Paz A., Maik-Rachline G., Gutkind N., Rosenberg S., Seger R. & Samuels Y. (2019),
  • A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival

    Authors: Sharbi-Yunger A., Grees M., Cafri G., Bassan D., Eichmuller S. B., Tzehoval E., Utikal J., Umansky V. & Eisenbach L. (2019), International Journal of Cancer. 144, 4, p. 909-921
  • Tumor diversity and the trade-off between universal cancer tasks

    Authors: Hausser J., Szekely P., Bar N., Zimmer A., Sheftel H., Caldas C. & Alon U. (2019), Nature Communications. 10, 5423
  • Imaging of Red-Shifted Light From Bioluminescent Tumors Using Fluorescence by Unbound Excitation From Luminescence

    Authors: Sonego F., Bouccara S., Pons T., Lequeux N., Danckaert A., Tinevez J., Alam I. S., Shorte S. L. & Tournebize R. (2019), Frontiers in Bioengineering and Biotechnology. 7, APR, p. 73, 73
  • Adipocytes sensitize melanoma cells to environmental TGF-beta cues by repressing the expression of miR-211

    Authors: Golan T., Parikh R., Jacob E., Vaknine H., Zemser-Werner V., Hershkovitz D., Malcov H., Leibou S., Reichman H., Sheinboim D., Percik R., Amar S., Brenner R., Greenberger S., Kung A., Khaled M. & Levy C. (2019), Science Signaling. 12, 591, 6847
  • Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies

    Authors: Maron R., Schechter B., Nataraj N. B., Ghosh S., Romaniello D., Marrocco I., Noronha A., Carvalho S., Yarden Y. & Sela M. (2019), Biochemical and Biophysical Research Communications. 513, 1, p. 219-225
  • Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells

    Authors: Revach O., Sandler O., Samuels Y. & Geiger B. (2019), Cancer Research. 79, 10, p. 2634-2648
  • Cancer exome-based identification of tumor neo-antigens using mass spectrometry

  • Immunohistochemical quantification of partial-EMT in oral cavity squamous cell carcinoma primary tumors is associated with nodal metastasis

    Authors: Parikh A. S., Puram S. V., Faquin W. C., Richmon J. D., Emerick K. S., Deschler D. G., Varvares M. A., Tirosh I., Bernstein B. E. & Lin D. T. (2019), Oral Oncology. 99, 104458
  • Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2

    Authors: Malakar P., Stein I., Saragovi A., Winkler R., Stern-Ginossar N., Berger M., Pikarsky E. & Karni R. (2019), Cancer Research. 79, 10, p. 2480-2493
  • Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities

    Authors: Sana G., Madigan J. P., Gartner J. J., Fourrez M., Lin J., Qutob N., Narayan J., Shukla S., Ambudkar S. V., Xia D., Rosenberg S. A., Gottesman M. M., Samuels Y. & Gillet J. (2019), Journal of Investigative Dermatology. 139, 9, p. 1985-1992
  • SLAMF receptors on normal and malignant B cells

    Authors: Shachar I., Barak A., Lewinsky H., Sever L. & Radomir L. (2019), Clinical Immunology. 204, p. 23-30
  • The cancer microbiome

    Authors: Elinav E., Garrett W. S., Trinchieri G. & Wargo J. (2019), Nature Reviews Cancer. 19, 7, p. 371-376
  • Single-Cell RNA Sequencing in Cancer: Lessons Learned and Emerging Challenges

    Authors: Suva M. L. & Tirosh I. (2019), Molecular Cell. 75, 1, p. 7-12
  • AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer

    Authors: Kubli S. P., Bassi C., Roux C., Wakeham A., Gobl C., Zhou W., Jafari S. M., Snow B., Jones L., Palomero L., Thu K. L., Cassetta L., Soong D., Berger T., Ramachandran P., Baniasadi S. P., Duncan G., Lindzen M., Yarden Y., Herranz C., Lazaro C., Chu M. F., Haight J., Tinto P., Silvester J., Cescon D. W., Petit A., Pettersson S., Pollard J. W., Mak T. W., Pujana M. A., Cappello P. & Gorrini C. (2019), Proceedings of the National Academy of Sciences of the United States of America. 116, 9, p. 3604-3613
  • Deciphering Human Tumor Biology by Single-Cell Expression Profiling

  • KLF4 sensitizes the colon cancer cell HCT-15 to cisplatin by altering the expression of HMGB1 and hTERT

    Authors: Yadav S. S., Kumar M., Varshney A. & Yadava P. K. (2019), Life Sciences. 220, p. 169-176
  • Kinetic modeling of DUSP regulation in herceptin-resistant HER2-positive breast cancer

    Authors: Buiga P., Elson A., Tabernero L. & Schwartz J. M. (2019), Genes. 10, 8, 568
  • In vivo effects of temperature on the heart and pyloric rhythms in the crab Cancer borealis

    Authors: Kushinsky D., Morozova E. O. & Marder E. (2019), Journal of Experimental Biology. 222, 5, 199190
  • Liver and Steroid Hormones - Can a Touch of p53 Make a Difference?

    Authors: Charni-Natan M., Aloni-Grinstein R., Osher E. & Rotter V. (2019), Frontiers in Endocrinology. 10, 374
  • Genome-wide miRNA methylome analysis in oral cancer: possible biomarkers associated with patient survival

    Authors: Roy R., Chatterjee A., Das D., Ray A., Singh R., Chattopadhyay E., De Sarkar N., Eccles M., Pal M., Maitra A. & Roy B. (2019), Epigenomics. 11, 5, p. 473-487
  • Transient p53-Mediated Regenerative Senescence in the Injured Heart

    Authors: Sarig R., Rimmer R., Bassat E., Zhang L., Umansky K. B., Lendengolts D., Perlmoter G., Yaniv K. & Tzahor E. (2019), Circulation. 139, 21, p. 2491-2494
  • Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018)

    Authors: Qutob N., Masuho I., Alon M., Emmanuel R., Cohen I., Di Pizio A., Madore J., Elkahloun A., Ziv T., Levy R., Gartner J. J., Hill V. K., Lin J. C., Hevroni Y., Greenberg P., Brodezki A., Rosenberg S. A., Kosloff M., Hayward N. K., Admon A., Niv M. Y., Scolyer R. A., Martemyanov K. A. & Samuels Y. (2019),
  • Corrigendum to 'p53 balances between tissue hierarchy and anarchy'

    Authors: Koifman G., Aloni-Grinstein R. & Rotter V. (2019), Journal of Molecular Cell Biology. 11, 12, p. 1106
  • Modelling the role of dual specificity phosphatases in herceptin resistant breast cancer cell lines

    Authors: Buiga P., Elson A., Tabernero L. & Schwartz J. (2019), Computational Biology and Chemistry. 80, p. 138-146
  • Increased expression of cathepsin D is required for L1-mediated colon cancer progression

    Authors: Basu S., Cheriyamundath S., Gavert N., Brabletz T., Haase G. & Ben-Ze'ev A. (2019), Oncotarget. 10, 50, p. 5217-5228
  • Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma

    Authors: Li H., van der Leun A. M., Yofe I., Lubling Y., Gelbard-Solodkin D., van Akkooi A. C. J., van den Braber M., Rozeman E. A., Haanen J. B. A. G., Blank C. U., Horlings H. M., David E., Baran Y., Bercovich A., Lifshitz A., Schumacher T. N., Tanay A. & Amit I. (2019), Cell. 176, 4, p. 775-789.e18
  • Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types

    Authors: Ben-Hamo R., Zilberberg A., Cohen H., Bahar-Shany K., Wachtel C., Korach J., Aviel-Ronen S., Barshack I., Barash D., Levanon K. & Efroni S. (2019), Npj precision oncology. 3, p. 12, 12
  • Reduced CTL motility and activity in avascular tumor areas

    Authors: Manaster Y., Shipony Z., Hutzler A., Kolesnikov M., Avivi C., Shalmon B., Barshack I., Besser M. J., Feferman T. & Shakhar G. (2019), Cancer Immunology Immunotherapy. 68, 8, p. 1287-1301
  • The transcriptional profile of circulating myeloid derived suppressor cells correlates with tumor development and progression in mouse

    Authors: Nachmany I., Bogoch Y., Friedlander-Malik G., Amar O., Bondar E., Zohar N., Hantisteanu S., Fainaru O., Lubezky N., Klausner J. M. & Pencovich N. (2019), Genes and Immunity. 20, 7, p. 589-598
  • IKK epsilon regulates the breast cancer stem cell phenotype

    Authors: Orlova Z., Pruefer F., Castro-Oropeza R., Ordaz-Ramos A., Zampedri C., Maldonado V., Vazquez-Santillan K. & Melendez-Zajgla J. (2019), Biochimica et Biophysica Acta - Molecular Cell Research. 1866, 4, p. 598-611
  • c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression

    Authors: Sim W. J., Iyengar P. V., Lama D., Lui S. K. L., Ng H. C., Haviv-Shapira L., Domany E., Kappei D., Tan T. Z., Saie A., Jaynes P. W., Verma C. S., Kumar A. P., Rouanne M., Ha H. K., Radulescu C., ten Dijke P., Eichhorn P. J. A. & Thiery J. P. (2019), Nature Communications. 10, 4349
  • The ADAM17 Protease Promotes Tobacco Smoke Carcinogen-induced Lung Tumourigenesis

    Authors: Saad M. I., McLeod L., Yu L., Ebi H., Ruwanpura S., Sagi I., Rose-John S. & Jenkins B. J. (2019), Carcinogenesis.
  • A cancer associated somatic mutation in LC3B attenuates its binding to E1-like ATG7 protein and subsequent lipidation

    Authors: Nuta G. C., Gilad Y., Gershoni M., Sznajderman A., Schlesinger T., Bialik S., Eisenstein M., Pietrokovski S. & Kimchi A. (2019), Autophagy. 15, 3, p. 438-452
  • Accelerated Hypofractionated Radiation Therapy for Elderly Frail Bladder Cancer Patients Unfit for Surgery or Chemotherapy

    Authors: Hammer L., Laufer M., Dotan Z., Leibowitz-Amit R., Berger R., Felder S., Weiss I., Lawrence Y. R. & Symon Z. (2019), American Journal Of Clinical Oncology-Cancer Clinical Trials. 42, 2, p. 179-183
  • Daily light and darkness onset and circadian rhythms metabolically synchronize hematopoietic stem cell differentiation and maintenance: The role of bone marrow norepinephrine, tumor necrosis factor, and melatonin cycles

    Authors: Golan K., Kollet O., Markus R. P. & Lapidot T. (2019), Experimental Hematology. 78, p. 1-10
  • The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment

    Authors: Verduci L., Strano S., Yarden Y. & Blandino G. (2019), Molecular Oncology. 13, 4, p. 669-680
  • Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis

    Authors: Anuj, Arivazhagan L., Venkatraman G. & Rayala S. K. (2019), Molecular and Cellular Biology. 39, 7, UNSP e0057
  • Melanoma-derived extracellular vesicles instigate proinflammatory signaling in the metastatic microenvironment

    Authors: Lahav T. G., Adler O., Zait Y., Shani O., Amer M., Doron H., Abramovitz L., Yofe I., Cohen N. & Erez N. (2019), International Journal of Cancer. 145, 9, p. 2521-2534
  • Nonmuscle myosin IIA and IIB differentially modulate migration and alter gene expression in primary mouse tumorigenic cells

    Authors: Halder D., Saha S., Singh R. K., Ghosh I., Mallick D., Dey S. K., Ghosh A., Das B. B., Ghosh S. & Jana S. S. (2019), Molecular Biology of the Cell. 30, 12, p. 1463-1476
  • Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators

    Authors: Conniot J., Scomparin A., Peres C., Yeini E., Pozzi S., Matos A., Kleiner R., Moura L. I. F., Zupancic E., Viana A. S., Doron H., Gois P. M. P., Erez N., Jung S., Satchi-Fainaro R. & Florindo H. F. (2019), Nature Nanotechnology. 14, 9, p. 891-901
  • p53: not just a tumor suppressor

  • Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis

    Authors: Stein Y., Rotter V. & Aloni-Grinstein R. (2019), International Journal of Molecular Sciences. 20, 24, 6197
  • ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer

    Authors: Saad M. I., Alhayyani S., McLeod L., Yu L., Alanazi M., Deswaerte V., Tang K., Jarde T., Smith J. A., Prodanovic Z., Tate M. D., Balic J. J., Watkins D. N., Cain J. E., Bozinovski S., Algar E., Kohmoto T., Ebi H., Ferlin W., Garbers C., Ruwanpura S., Sagi I., Rose-John S. & Jenkins B. J. (2019), EMBO Molecular Medicine. 11, 4, 9976
  • RASA2 and NF1; two-negative regulators of Ras with complementary functions in melanoma

    Authors: Arafeh R., Di Pizio A., Elkahloun A. G., Dym O., Niv M. Y. & Samuels Y. (2019),
  • DNA Repair Biomarker for Lung Cancer Risk and its Correlation With Airway Cells Gene Expression

    Authors: Paz-Elizur T., Leitner-Dagan Y., Meyer K. B., Markus B., Giorgi F. M., O'Reilly M., Kim H., Evgy Y., Fluss R., Freedman L. S., Rintoul R. C., Ponder B. & Livneh Z. (2019), Jnci cancer spectrum. 4, 1, 067
  • Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer

    Authors: Shee K., Jiang A., Varn F. S., Liu S., Traphagen N. A., Owens P., Ma C. X., Hoog J., Cheng C., Golub T. R., Straussman R. & Miller T. W. (2019), FASEB Journal. 33, 2, p. 1644-1657
  • An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

    Authors: Neftel C., Laffy J., Filbin M. G., Hara T., Shore M. E., Rahme G. J., Richman A. R., Silverbush D., Shaw M. L., Hebert C. M., Dewitt J., Gritsch S., Perez E. M., Castro L. N. G., Lan X., Druck N., Rodman C., Dionne D., Kaplan A., Bertalan M. S., Small J., Pelton K., Becker S., Bonal D., Quang-De Nguyen, Servis R. L., Fung J. M., Mylvaganam R., Mayr L., Gojo J., Haberler C., Geyeregger R., Czech T., Slavc I., Nahed B., Curry W. T., Carter B. S., Wakimoto H., Brastianos P. K., Batchelor T. T., Stemmer-Rachamimov A., Martinez-Lage M., Frosch M. P., Stamenkovic I., Riggi N., Rheinbay E., Monje M., Rozenblatt-Rosen O., Cahill D. P., Patel A. P., Hunter T., Verma I. M., Ligon K. L., Louis D. N., Regev A., Bernstein B. E., Tirosh I. & Suva M. L. (2019), Cell. 178, 4, p. 835-849.e21
  • ISG15 induction is required during L1-mediated colon cancer progression and metastasis

    Authors: Cheriyamundath S., Basu S., Haase G., Doernberg H., Gavert N., Brabletz T. & Ben-Ze’ev A. (2019), Oncotarget. 10, 67, p. 7122-7131
  • Single-cell sequencing and its applications in head and neck cancer

    Authors: Qi Z., Barrett T., Parikh A. S., Tirosh I. & Puram S. V. (2019), Oral Oncology. 99, 104441
  • Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer

    Authors: Maik-Rachline G., Hacohen A. & Seger R. (2019), International Journal of Molecular Sciences. 20, 5, 1194
  • Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer A Review

    Authors: Calvillo-Arguelles O., Jaiswal S., Shlush L. I., Moslehi J. J., Schimmer A., Barac A. & Thavendiranathan P. (2019), JAMA Cardiology. 4, 4, p. 380-387
  • Effectiveness of the combination of vascular targeted photodynamic therapy and anti-cytotoxic T-lymphocyte-associated antigen 4 in a preclinical mouse model of urothelial carcinoma

    Authors: Corradi R. B., LaRosa S., Jebiwott S., Murray K. S., Rosenzweig B., Somma A. J., Gomez R. S., Scherz A., Kim K. & Coleman J. A. (2019), International Journal of Urology. 26, 3, p. 414-422
  • New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?

    Authors: Shreberk-Shaked M. & Oren M. (2019), Molecular Oncology. 13, 6, p. 1335-1341
  • Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients

    Authors: Gofrit O. N., Klein B. Y., Cohen I. R., Ben-Hur T., Greenblatt C. L. & Bercovier H. (2019), PLoS One. 14, 11, 0224433
  • UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma

    Authors: Wolf Y., Bartok O., Patkar S., Eli G. B., Cohen S., Litchfield K., Levy R., Jiménez-Sánchez A., Trabish S., Lee J. S., Karathia H., Barnea E., Day C., Cinnamon E., Stein I., Solomon A., Bitton L., Pérez-Guijarro E., Dubovik T., Shen-Orr S. S., Miller M. L., Merlino G., Levin Y., Pikarsky E., Eisenbach L., Admon A., Swanton C., Ruppin E. & Samuels Y. (2019), Cell. 179, 1, p. 219-235
  • PIK3CA in cancer: The past 30 years

    Authors: Arafeh R. & Samuels Y. (2019), Seminars in Cancer Biology. 59, p. 36-49
  • Transmissible inflammation-induced colorectal cancer in inflammasome-deficient mice

    Authors: Hu B., Friedman G., Elinav E. & Flavell R. A. (2019), OncoImmunology. 8, 10, 981995
  • Erratum: Cancer-Associated Eukaryotic Translation Initiation Factor 1A Mutants Impair Rps3 and Rps10 Binding and Enhance Scanning of Cell Cycle Genes (vol 39, e00441-18, 2019)

    Authors: Sehrawat U., Koning F., Ashkenazi S., Stelzer G., Leshkowitz D. & Dikstein R. (2019), Molecular and Cellular Biology. 39, 6, e00049-19
  • Exosomes as a storehouse of tissue remodeling proteases and mediators of cancer progression

    Authors: Das A., Mohan V., Krishnaswamy V. R., Solomonov I. & Sagi I. (2019), Cancer and Metastasis Reviews. 38, 3, p. 455-468
  • MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy

    Authors: Owyong M., Chou J., van den Bijgaart R. J., Kong N., Efe G., Maynard C., Talmi-Frank D., Solomonov I., Koopman C., Hadler-Olsen E., Headley M., Lin C., Wang C., Sagi I., Werb Z. & Plaks V. (2019), Life Science Alliance. 2, 6, 201800226
  • Cancer-Associated Eukaryotic Translation Initiation Factor 1A Mutants Impair Rps3 and Rps10 Binding and Enhance Scanning of Cell Cycle Genes

    Authors: Sehrawat U., Koning F., Ashkenazi S., Stelzer G., Leshkowitz D. & Dikstein R. (2019), Molecular and Cellular Biology. 39, 3, e00441-18
  • STAT3 Post-Translational Modifications Drive Cellular Signaling Pathways in Prostate Cancer Cells

    Authors: Cocchiola R., Rubini E., Altieri F., Chichiarelli S., Paglia G., Romaniello D., Carissimi S., Giorgi A., Giamogante F., Macone A., Perugia G., Gurtner A. & Eufemi M. (2019), International Journal of Molecular Sciences. 20, 8, 1815
  • Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

    Authors: Keskin D. B., Anandappa A. J., Sun J., Tirosh I., Mathewson N. D., Li S., Oliveira G., Giobbie-Hurder A., Felt K., Gjini E., Shukla S. A., Hu Z., Li L., Le P. M., Allesoe R. L., Richman A. R., Kowalczyk M. S., Abdelrahman S., Geduldig J. E., Charbonneau S., Pelton K., Iorgulescu J. B., Elagina L., Zhang W., Olive O., McCluskey C., Olsen L. R., Stevens J., Lane W. J., Salazar A. M., Daley H., Wen P. Y., Chiocca E. A., Harden M., Lennon N. J., Gabriel S., Getz G., Lander E. S., Regev A., Ritz J., Neuberg D., Rodig S. J., Ligon K. L., Suva M. L., Wucherpfennig K. W., Hacohen N., Fritsch E. F., Livak K. J., Ott P. A., Wu C. J. & Reardon D. A. (2019), Nature. 565, 7738, p. 234-239
  • The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer

    Authors: De Mattos-Arruda L., Sammut S., Ross E. M., Bashford-Rogers R., Greenstein E., Markus H., Morganella S., Teng Y., Maruvka Y., Pereira B., Rueda O. M., Chin S., Contente-Cuomo T., Mayor R., Arias A., Ali H. R., Cope W., Tiezzi D., Dariush A., Amarante T. D., Reshef D., Ciriaco N., Martinez-Saez E., Peg V., Ramon y Cajal S., Cortes J., Vassiliou G., Getz G., Nik-Zainal S., Murtaza M., Friedman N., Markowetz F., Seoane J. & Caldas C. (2019), Cell Reports. 27, 9, p. 2690-2708
  • Potential immunotherapy for Alzheimer disease and age-related dementia

    Authors: Schwartz M., Arad M. & Ben-Yehuda H. (2019), Dialogues in Clinical Neuroscience. 21, 1, p. 21-25
  • Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes

    Authors: Riquelme E., Zhang Y., Zhang L., Montiel M., Zoltan M., Dong W., Quesada P., Sahin I., Chandra V., San Lucas A., Scheet P., Xu H., Hanash S. M., Feng L., Burks J. K., Do K., Peterson C. B., Nejman D., Tzeng C. D., Kim M. P., Sears C. L., Ajami N., Petrosino J., Wood L. D., Maitra A., Straussman R., Katz M., White J. R., Jenq R., Wargo J. & McAllister F. (2019), Cell. 178, 4, p. 795-806, e1-e12
  • The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells

    Authors: Chan S. M., Sapir T., Park S., Rual J., Contreras-Galindo R., Reiner O. & Markovitz D. M. (2019), PLoS One. 14, 2, 0212970
  • Fast dose fractionation using ultra-short laser accelerated proton pulses can increase cancer cell mortality, which relies on functional PARP1 protein

    Authors: Bayart E., Flacco A., Delmas O., Pommarel L., Leyy D., Cayallone M., Megnin-Chanet F., Deutsch E. & Malka V. A. (2019), Scientific Reports. 9, 10132
  • Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer

    Authors: Lebdai S., Gigoux M., Alvim R., Somma A., Nagar K., Azzouzi A. R., Cussenot O., Merghoub T., Wolchok J. D., Scherz A., Kim K. & Coleman J. (2019), OncoImmunology. 8, 6, e1581528
  • Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer

    Authors: Hooda J., Novak M., Salomon M. P., Matsuba C., Ramos R. I., MacDuffie E., Song M., Hirsch M. S., Lester J., Parkash V., Karlan B. Y., Oren M., Hoon D. S. & Drapkin R. (2019), Cancer Research. 79, 4, p. 760-772
  • Mutant p53-a potential player in shaping the tumor-stroma crosstalk

    Authors: Stein Y., Aloni-Grinstein R. & Rotter V. (2019), Journal of Molecular Cell Biology. 11, 7, p. 600-604
  • Self-assembled micellar clusters based on Triton-X-family surfactants for enhanced solubilization, encapsulation, proteins permeability control, and anticancer drug delivery

    Authors: Solomonov A. V., Marfin Y. S., Rumyantsev E. V., Ragozin E., Zahavi T. S., Gellerman G., Tesler A. B., Muench F., Kumagai A. & Miyawaki A. (2019), Materials Science & Engineering: C-Materials For Biological Applications. 99, p. 794-804
  • p53 balances between tissue hierarchy and anarchy

    Authors: Koifman G., Aloni-Grinstein R. & Rotter V. (2019), Journal of Molecular Cell Biology. 11, 7, p. 553-563
  • Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas

    Authors: Dietz S., Lifshitz A., Kazdal D., Harms A., Endris V., Winter H., Stenzinger A., Warth A., Sill M., Tanay A. & Sueltmann H. (2019), International Journal of Cancer. 144, 5, p. 1061-1072
  • Hydrophobic Organic Components of Ambient Fine Particulate Matter (PM 2.5) Associated with Inflammatory Cellular Response.

    Authors: Jiang X., Xu F., Qiu X., Shi X., Pardo M., Shang Y., Wang J., Rudich Y. & Zhu T. (2019), Environmental Science & Technology. 53, 17, p. 10479-10486
  • Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer

    Authors: Silberman A., Goldman O., Assayag O. B., Jacob A., Rabinovich S., Adler L., Lee J. S., Keshet R., Sarver A., Frug J., Stettner N., Galai S., Persi E., Halpern K. B., Zaltsman-Amir Y., Pode-Shakked B., Eilam R., Anikster Y., Nagamani S. C. S., Ulitsky I., Ruppin E. & Erez A. (2019), Cancer Research. 79, 3, p. 518-533
  • Data on peptidyl platform-based anticancer drug synthesis and triton-x-based micellar clusters (MCs) self-assembly peculiarities for enhanced solubilization, encapsulation of hydrophobic compounds and their interaction with HeLa cells

    Authors: Solomonov A. V., Marfin Y. S., Rumyantsev E. V., Ragozin E., Zahavi T. S., Gellerman G., Tesler A. B., Muench F., Kumagai A. & Miyawaki A. (2019), Data in Brief. 25, 104052
  • Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy

    Authors: Lonetto G., Koifman G., Silberman A., Attery A., Solomon H., Levin-Zaidman S., Goldfinger N., Porat Z., Erez A. & Rotter V. (2019), Cell Death and Differentiation. 26, 9, p. 1566-1581
  • p53 and the Viral Connection: Back into the Future

    Authors: Aloni-Grinstein R., Charni-Natan M., Solomon H. & Rotter V. (2018), Cancers. 10, 6, 178
  • Cancer research in the era of immunogenomics

    Authors: Wolf Y. & Samuels Y. (2018), ESMO Open. 3, 7, 000475
  • Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results

    Authors: Furman-Haran E., Nissan N., Ricart-Selma V., Martinez-Rubio C., Degani H. & Camps-Herrero J. (2018), Jmri-Journal Of Magnetic Resonance Imaging. 47, 4, p. 1080-1090
  • Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers

    Authors: Solomon H., Dinowitz N., Pateras I. S., Cooks T., Shetzer Y., Molchadsky A., Charni M., Rabani S., Koifman G., Tarcic O., Porat Z., Kogan-Sakin I., Goldfinger N., Oren M., Harris C. C., Gorgoulis V. G. & Rotter V. (2018), Oncogene. 37, 12, p. 1669-1684
  • Regulation of dual specificity phosphatases in breast cancer during initial treatment with Herceptin: a Boolean model analysis

    Authors: Buiga P., Elson A., Tabernero L. & Schwartz J. (2018), BMC Systems Biology. 12, Suppl 1, p. 13-24, 11
  • Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma

    Authors: Yu Y., Schleich K., Yue B., Ji S., Lohneis P., Kemper K., Silvis M. S., Qutob N., van Rooijen E., Werner-Klein M., Li L., Dhawan D., Meierjohann S., Reimann M., Elkahloun A., Treitschke S., Dörken B., Speck C., Mallette F. A., Zon L. I., Holmen S. L., Peeper D. S., Samuels Y., Schmitt C. A. & Lee S. (2018), Cancer Cell. 33, 2, p. 322-336.e8
  • Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy

    Authors: Bar-Shir A., Alon L., Korrer M. J., Lim H. S., Yadav N. N., Kato Y., Pathak A. P., Bulte J. W. M. & Gilad A. A. (2018), Magnetic Resonance in Medicine. 79, 2, p. 1010-1019
  • Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

    Authors: Filbin M. G., Tirosh I., Hovestadt V., Shaw M. L., Escalante L. E., Mathewson N. D., Neftel C., Frank N., Pelton K., Hebert C., Haberler C., Yizhak K., Gojo J., Egervari K., Mount C., van Galen P., Bonal D. M., Quang-De Nguyen, Beck A., Sinai C., Czech T., Dorfer C., Goumnerova L., Lavarino C., Carcaboso A. M., Mora J., Mylvaganam R., Luo C. C., Peyrl A., Popovic M., Azizi A., Batchelor T. T., Frosch M. P., Martinez-Lage M., Kieran M. W., Bandopadhayay P., Beroukhim R., Fritsch G., Getz G., Rozenblatt-Rosen O., Wucherpfennig K. W., Louis D. N., Monje M., Slavc I., Ligon K. L., Golub T. R., Regev A., Bernstein B. E. & Suva M. L. (2018), Science. 360, 6386, p. 331-335
  • The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies

  • Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies

    Authors: Roncato F., Rruga F., Porcu E., Casarin E., Ronca R., Maccarinelli F., Realdon N., Basso G., Alon R., Viola G. & Morpurgo M. (2018), Nature Communications. 9, 4070
  • A combined computational-experimental approach to define the structural origin of antibody recognition of sialyl-Tn, a tumor-associated carbohydrate antigen

    Authors: Amon R., Grant O. C., Ben-Arye S. L., Makeneni S., Nivedha A. K., Marshanski T., Norn C., Yu H., Glushka J. N., Fleishman S. J., Chen X., Woods R. J. & Padler-Karavani V. (2018), Scientific Reports. 8, 10786
  • Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4

    Authors: Nordlinger A., Dror S., Elkahloun A., Del Rio J., Stubbs E., Golan T., Malcov H., Pricket T. D., Cronin J. C., Parikh S., Labes S., Thomas L., Yankovitz G., Tabach Y., Levy C., Samuels Y. & Khaled M. (2018), Journal of Investigative Dermatology. 138, 10, p. 2216-2223
  • Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer

    Authors: Shin S., Müller A., Verma N., Lev S. & Nguyen L. K. (2018), PLoS Computational Biology. 14, 6, 1006192
  • A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment

    Authors: Griveau A., Seano G., Shelton S. J., Kupp R., Jahangiri A., Obernier K., Krishnan S., Lindberg O. R., Yuen T. J., Tien A., Sabo J. K., Wang N., Chen I., Kloepper J., Larrouquere L., Ghosh M., Tirosh I., Huillard E., Alvarez-Buylla A., Oldham M. C., Persson A. I., Weiss W. A., Batchelor T. T., Stemmer-Rachamimov A., Suva M. L., Phillips J. J., Aghi M. K., Mehta S., Jain R. K. & Rowitch D. H. (2018), Cancer Cell. 33, 5, p. 874-889
  • Intratumoral bacteria may elicit chemoresistance by metabolizing anticancer agents

    Authors: Geller L. T. & Straussman R. (2018), Molecular and Cellular Oncology. 5, 1, e1405139
  • Induction of Nitric-Oxide Metabolism in Enterocytes Alleviates Colitis and Inflammation-Associated Colon Cancer

    Authors: Stettner N., Rosen C., Bernshtein B., Gur-Cohen S., Frug J., Silberman A., Sarver A., Carmel-Neiderman N. N., Eilam R., Biton I., Pevsner-Fischer M., Zmora N., Brandis A., Halpern K. B., Mazkereth R., di Bernardo D., Brunetti-Pierri N., Premkumar M. H., Dank G., Nagamani S. C. S., Jung S., Harmelin A. & Erez A. (2018), Cell Reports. 23, 7, p. 1962-1976
  • Expansion and Antitumor Cytotoxicity of T-Cells Are Augmented by Substrate-Bound CCL21 and Intercellular Adhesion Molecule 1

    Authors: Adutler-Lieber S., Friedman N. & Geiger B. (2018), Frontiers in Immunology. 9, 1303
  • Stepping out of the shadows: Oncogenic and tumor-promoting protein tyrosine phosphatases

  • International conference on Cell Death in Cancer and Toxicology 2018 (CDCT-2018)

    Authors: Ansari K. M., Arany P. R., Arama E., Larisch S., Birge R. B. & Chandra D. (2018), Cell Communication and Signaling. 16, 34
  • Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer

    Authors: Shee K., Yang W., Hinds J. W., Hampsch R. A., Varn F. S., Traphagen N. A., Patel K., Cheng C., Jenkins N. P., Kettenbach A. N., Demidenko E., Owens P., Faber A. C., Golub T. R., Straussman R. & Miller T. W. (2018), Journal of Experimental Medicine. 215, 3, p. 895-910
  • NKp46 Receptor-Mediated Interferon-gamma Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis

    Authors: Glasner A., Levi A., Enk J., Isaacson B., Viukov S., Orlanski S., Scope A., Neuman T., Enk C. D., Hanna J. H., Sexl V., Jonjic S., Seliger B., Zitvogel L. & Mandelboim O. (2018), Immunity. 48, 1, p. 107-+
  • Analysis of enzymatic activity of matrix metalloproteinase (MMP) by collagen zymography in Melanoma

  • Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy

    Authors: Grinshpun A., Gavert N., Granit R. Z., Masuri H., Ben-Porath I., Breuer S., Zick A., Rosenberg S., Maoz M., Granit A., Pikarsky E., Straussman R., Peretz T. & Sonnenblick A. (2018), Cancer Biology and Therapy. 19, 8, p. 645-648
  • Harnessing synthetic lethality to predict the response to cancer treatment

    Authors: Lee J. S., Das A., Jerby-Arnon L., Arafeh R., Auslander N., Davidson M., McGarry L., James D., Amzallag A., Park S. G., Cheng K., Robinson W., Atias D., Stossel C., Buzhor E., Stein G., Waterfall J. J., Meltzer P. S., Golan T., Hannenhalli S., Gottlieb E., Benes C. H., Samuels Y., Shanks E. & Ruppin E. (2018), Nature Communications. 9, 2546
  • Cell-cell adhesion: linking Wnt/β-catenin signaling with partial EMT and stemness traits in tumorigenesis

    Authors: Basu S., Cheriyamundath S. & Ben-Ze'ev A. (2018), F1000Research. 7
  • Phagocyte-extracellular matrix crosstalk empowers tumor development and dissemination

    Authors: Varol C. & Sagi I. (2018), The FEBS journal. 285, 4, p. 734-751
  • Prediction of acute myeloid leukaemia risk in healthy individuals

    Authors: Abelson S., Collord G., Ng S. W. K., Weissbrod O., Mendelson Cohen N., Niemeyer E., Barda N., Zuzarte P. C., Heisler L., Sundaravadanam Y., Luben R., Hayat S., Wang T. T., Zhao Z., Cirlan I., Pugh T. J., Soave D., Ng K., Latimer C., Hardy C., Raine K., Jones D., Hoult D., Britten A., McPherson J. D., Johansson M., Mbabaali F., Eagles J., Miller J. K., Pasternack D., Timms L., Krzyzanowski P., Awadalla P., Costa R., Segal E., Bratman S. V., Beer P., Behjati S., Martincorena I., Wang J. C. Y., Bowles K. M., Quirós J. R., Karakatsani A., La Vecchia C., Trichopoulou A., Salamanca-Fernández E., Huerta J. M., Barricarte A., Travis R. C., Tumino R., Masala G., Boeing H., Panico S., Kaaks R., Krämer A., Sieri S., Riboli E., Vineis P., Foll M., McKay J., Polidoro S., Sala N., Khaw K., Vermeulen R., Campbell P. J., Papaemmanuil E., Minden M. D., Tanay A., Balicer R. D., Wareham N. J., Gerstung M., Dick J. E., Brennan P., Vassiliou G. S. & Shlush L. I. (2018), Nature. 559, 7714, p. 400-404
  • CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma

    Authors: Alon M., Arafeh R., Lee J. S., Madan S., Kalaora S., Nagler A., Abgarian T., Greenberg P., Ruppin E. & Samuels Y. (2018), Oncotarget. 9, 58, p. 31264-31277
  • Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanoma

    Authors: Alon M., Emmanuel R., Qutob N., Bakhman A., Peshti V., Brodezki A., Bassan D., Kosloff M. & Samuels Y. (2018), Pigment Cell and Melanoma Research. 31, 5, p. 641-648
  • Single cell RNA-seq highlights a role for a partial EMT in head and neck cancer

    Authors: Puram S. V., Parikh A. S. & Tirosh I. (2018), Molecular & cellular oncology. 5, 3, e1448244
  • Dual role of E-cadherin in the regulation of invasive collective migration of mammary carcinoma cells

    Authors: Elisha Y., Kalchenko V., Kuznetsov Y. & Geiger B. (2018), Scientific Reports. 8, 4986
  • PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma

    Authors: Ghannam-Shahbari D., Jacob E., Kakun R. R., Wasserman T., Korsensky L., Sternfeld O., Kagan J., Bublik D. R., Aviel-Ronen S., Levanon K., Sabo E., Larisch S., Oren M., Hershkovitz D. & Perets R. (2018), Oncogene. 37, 17, p. 2213-2224
  • Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity

  • Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma

    Authors: Kalaora S., Wolf Y., Feferman T., Barnea E., Greenstein E., Reshef D., Tirosh I., Reuben A., Patkar S., Levy R., Quinkhardt J., Omokoko T., Qutob N., Golani O., Zhang J., Mao X., Song X., Bernatchez C., Haymaker C., Forget M., Creasy C., Greenberg P., Carter B. W., Cooper Z. A., Rosenberg S. A., Lotem M., Sahin U., Shakhar G., Ruppin E., Wargo J. A., Friedman N., Admon A. & Samuels Y. (2018), Cancer Discovery. 8, 11, p. 1366-1375
  • A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways

    Authors: Romaniello D., Mazzeo L., Mancini M., Marrocco I., Noronha A., Kreitman M., Srivastava S., Ghosh S., Lindzen M., Salame T. M., Onn A., Bar J. & Yarden Y. (2018), Clinical Cancer Research. 24, 22, p. 5610-5621
  • Rewiring urea cycle metabolism in cancer to support anabolism

    Authors: Keshet R., Szlosarek P., Carracedo A. & Erez A. (2018), Nature Reviews Cancer. 18, 10, p. 634-645
  • A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation

    Authors: Kotler E., Shani O., Goldfeld G., Lotan-Pompan M., Tarcic O., Gershoni A., Hopf T. A., Marks D. S., Oren M. & Segal E. (2018), Molecular Cell. 71, 1, p. 178-190.e8
  • Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia

    Authors: Gutjahr J. C., Szenes E., Tschech L., Asslaber D., Schlederer M., Roos S., Yu X., Girbl T., Sternberg C., Egle A., Aberger F., Alon R., Kenner L., Greil R., Orian-Rousseau V. & Hartmann T. N. (2018), Blood. 131, 12, p. 1337-1349
  • A biological-computational human cell lineage discovery platform based on duplex molecular inversion probes

    Authors: Tao L., Raz O., Marx Z., Biezuner T., Amir S., Milo L., Adar R., Onn A., Chapal-Ilani N., Berman V., Levy R., Oron B., Halaban R. & Shapiro E. (2018), BioRxiv.
  • Differentiation Between Vasogenic Edema and Infiltrative Tumor in Patients With High-Grade Gliomas Using Texture Patch-Based Analysis

    Authors: Artzi M., Liberman G., Blumenthal D. T., Aizenstein O., Bokstein F. & Ben Bashat D. (2018), Jmri-Journal Of Magnetic Resonance Imaging. 48, 3, p. 729-736
  • Loss of C/EBP-beta LIP drives cisplatin resistance in malignant pleural mesothelioma

    Authors: Kopecka J., Salaroglio I. C., Righi L., Libener R., Orecchia S., Grosso F., Milosevic V., Ananthanarayanan P., Ricci L., Capelletto E., Pradotto M., Napoli F., Di Maio M., Novello S., Rubinstein M., Scagliotti G. V. & Riganti C. (2018), Lung Cancer. 120, p. 34-45
  • p53 in Bronchial Club Cells Facilitates Chronic Lung Inflammation by Promoting Senescence

    Authors: Sagiv A., Bar-Shai A., Levi N., Hatzav M., Zada L., Ovadya Y., Roitman L., Manella G., Regev O., Majewska J., Vadai E., Eilam R., Feigelson S. W., Tsoory M., Tauc M., Alon R. & Krizhanovsky V. (2018), Cell Reports. 22, 13, p. 3468-3479
  • Functional characterization of the p53 "mutome"

    Authors: Kotler E., Segal E. & Oren M. (2018), Molecular & cellular oncology. 5, 6, 1511207
  • A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells

    Authors: Koifman G., Shetzer Y., Eizenberger S., Solomon H., Rotkopf R., Molchadsky A., Lonetto G., Goldfinger N. & Rotter V. (2018), Cancer Research. 78, 20, p. 5833-5847
  • LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state

    Authors: Furth N., Pateras I. S., Rotkopf R., Vlachou V., Rivkin I., Schmitt I., Bakaev D., Gershoni A., Ainbinder E., Leshkowitz D., Johnson R. L., Gorgoulis V. G., Oren M. & Aylon Y. (2018), Life science alliance. 1, 5, 201800171
  • Increasing intratumor C/EBP- LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

    Authors: Salaroglio I. C., Gazzano E., Abdullrahman A., Mungo E., Castella B., Abd-elrahman G. E. F. A., Massaia M., Donadelli M., Rubinstein M., Riganti C. & Kopecka J. (2018), Journal Of Experimental & Clinical Cancer Research. 37, 286
  • The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota

    Authors: Alteber Z., Sharbi-Yunger A., Pevsner-Fischer M., Blat D., Roitman L., Tzehoval E., Elinav E. & Eisenbach L. (2018), Immunology and Cell Biology. 96, 3, p. 284-297
  • The immune system profoundly restricts intratumor genetic heterogeneity

    Authors: Milo I., Bedora-Faure M., Garcia Z., Thibaut R., Perie L., Shakhar G., Deriano L. & Bousso P. (2018), Science immunology. 3, 29, 1435
  • MRI radiomics analysis of molecular alterations in low-grade gliomas

    Authors: Shofty B., Artzi M., Ben Bashat D., Liberman G., Haim O., Kashanian A., Bokstein F., Blumenthal D. T., Ram Z. & Shahar T. (2018), Computer-Assisted Radiology and Surgery. 13, 4, p. 563-571
  • An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors

    Authors: Mancini M., Gal H., Gaborit N., Mazzeo L., Romaniello D., Salame T. M., Lindzen M., Mahlknecht G., Enuka Y., Burton D. G. A., Roth L., Noronha A., Marrocco I., Adreka D., Altstadter R. E., Bousquet E., Downward J., Maraver A., Krizhanovsky V. & Yarden Y. (2018), EMBO Molecular Medicine. 10, 2, p. 294-308
  • Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer

    Authors: Zupancic E., Curato C., Kim J., Yeini E., Porat Z., Viana A. S., Globerson-Levin A., Waks T., Eshhar Z., Moreira J. N., Satchi-Fainaro R., Eisenbach L., Jung S. & Florindo H. F. (2018), Nanomedicine: Nanotechnology, Biology, and Medicine. 14, 3, p. 835-847
  • The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression

    Authors: Basu S., Gavert N., Brabletz T. & Ben-Ze'ev A. (2018), Cancer Letters. 424, p. 9-18
  • Assembly and activation of the Hippo signalome by FAT1 tumor suppressor

    Authors: Martin D., Degese M. S., Vitale-Cross L., Iglesias-Bartolome R., Valera J. L. C., Wang Z., Feng X., Yeerna H., Vadmal V., Moroishi T., Thorne R. F., Zaida M., Siegele B., Cheong S. C., Molinolo A. A., Samuels Y., Tamayo P., Guan K. L., Lippman S. M., Lyons J. G. & Gutkind J. S. (2018), Nature Communications. 9, 2372
  • Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models

    Authors: Grees M., Sharbi-Yunger A., Evangelou C., Baumann D., Cafri G., Tzehoval E., Eichmueller S. B., Offringa R., Utikal J., Eisenbach L. & Umansky V. (2018), OncoImmunology. 7, 7, 1445457
  • A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging

    Authors: Keren L., Bosse M., Marquez D., Angoshtari R., Jain S., Varma S., Yang S., Kurian A., Van Valen D., West R., Bendall S. C. & Angelo M. (2018), Cell. 174, 6, p. 1373-1387
  • TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma

    Authors: , Jethwa A., Slabicki M., Huellein J., Jentzsch M., Dala V., Rabe S., Wagner L., Walther T., Klapper W., Bohnenberger H., Rettel M., Lu J., Smits A. H., Stein F., Savitski M. M., Huber W., Aylon Y., Oren M. & Zenz T. (2018), Blood. 131, 25, p. 2789-2802
  • Arginine and the metabolic regulation of nitric oxide synthesis in cancer

    Authors: Keshet R. & Erez A. (2018), Disease Models & Mechanisms. 11, 8, dmm033332
  • Intratumor heterogeneity in epigenetic patterns

    Authors: Assenov Y., Brocks D. & Gerhaeuser C. (2018), Seminars in Cancer Biology. 51, p. 12-21
  • Laplacian pyramid based data fusion for high resolution dynamic MRI

    Authors: Pollack-Zuckerman L., Weizman L., Eldar Y. C., Ben Bashar D., Arzi M. & Irani M. (2018), ISMRM France, 2018.
  • SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors

    Authors: Roth L., Srivastava S., Lindzen M., Sas-Chen A., Sheffer M., Lauriola M., Enuka Y., Noronha A., Mancini M., Lavi S., Tarcic G., Pines G., Nevo N., Heyman O., Ziv T., Rueda O. M., Gnocchi D., Pikarski E., Admon A., Caldas C. & Yarden Y. (2018), Science Signaling. 11, 515, 0949
  • Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner

    Authors: Charni-Natan M., Solomon H., Molchadsky A., Jacob-Berger A., Goldfinger N. & Rotter V. (2018), Cell Death and Disease. 9, 647
  • RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells

    Authors: Qutob N., Masuho I., Alon M., Emmanuel R., Cohen I., Di Pizio A., Madore J., Elkahloun A., Ziv T., Levy R., Gartner J. J., Hill V. K., Lin J. C., Hevroni Y., Greenberg P., Brodezki A., Rosenberg S. A., Kosloff M., Hayward N. K., Admon A., Niv M. Y., Scolyer R. A., Martemyanov K. A. & Samuels Y. (2018), Scientific Reports. 8, 653
  • Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability

    Authors: Galanos P., Pappas G., Polyzos A., Kotsinas A., Svolaki I., Giakoumakis N. N., Glytsou C., Pateras I. S., Swain U., Souliotis V. L., Georgakilas A. G., Geacintov N., Scorrano L., Lukas C., Lukas J., Livneh Z., Lygerou Z., Chowdhury D., Sorensen C. S., Bartek J. & Gorgoulis V. G. (2018), GENOME BIOLOGY. 19, 37
  • CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia

    Authors: Lewinsky H., Barak A. F., Huber V., Kramer M. P., Radomir L., Sever L., Orr I., Mirkin V., Dezorella N., Shapiro M., Cohen Y., Shvidel L., Seiffert M., Herishanu Y., Becker-Herman S. & Shachar I. (2018), Journal of Clinical Investigation. 128, 12, p. 5465-5478
  • Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features

    Authors: Arandkar S., Furth N., Elisha Y., Belugali Nataraj N., van der Kuip H., Yarden Y., Aulitzky W., Ulitsky I., Geiger B. & Oren M. (2018), Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415
  • The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia

    Authors: Wakim J., Arman E., Becker Herman S., Kramer M. P., Bakos E., Shachar I. & Elson A. (2017), Oncogene. 36, 26, p. 3686-3694
  • Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis

    Authors: Edison N., Curtz Y., Paland N., Mamriev D., Chorubczyk N., Haviv-Reingewertz T., Kfir N., Morgenstern D., Kupervaser M., Kagan J., Kim H. T. & Larisch S. (2017), Cell Reports. 21, 2, p. 442-454
  • Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor

    Authors: Zimmer A., Amar Farkash F. S., Danon T. & Alon U. (2017), BMC Systems Biology. 11, 33
  • Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice

    Authors: Bogoch Y., Friedlander-Malik G., Lupu L., Bondar E., Zohar N., Langier S., Ram Z., Nachmany I., Klausner J. M. & Pencovich N. (2017), Tumor Biology. 39, 4
  • Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

    Authors: Geller L. T., Barzily-Rokni M., Danino T., Jonas O. H., Shental N., Nejman D., Gavert N., Zwang Y., Cooper Z. A., Shee K., Thaiss C. A., Reuben A., Livny J., Avraham R., Frederick D. T., Ligorio M., Chatman K., Johnston S. E., Mosher C. M., Brandis A., Fuks G., Gurbatri C., Gopalakrishnan V., Kim M., Hurd M. W., Katz M., Fleming J., Maitra A., Smith D. A., Skalak M., Bu J., Michaud M., Trauger S. A., Barshack I., Golan T., Sandbank J., Flaherty K. T., Mandinova A., Garrett W. S., Thayer S. P., Ferrone C. R., Huttenhower C., Bhatia S. N., Gevers D., Wargo J. A., Golub T. R. & Straussman R. (2017), Science. 357, 6356, p. 1156-1160
  • Prediction of drug cocktail effects when the number of measurements is limited

    Authors: Zimmer A., Tendler A., Katzir I., Mayo A. & Alon U. (2017), PLoS Biology. 15, 10, e2002518
  • Runx3 in Immunity, Inflammation and Cancer

  • Diverse p53/DNA binding modes expand the repertoire of p53 response elements

    Authors: Vyas P., Beno I., Xi Z., Stein Y., Golovenko D., Kessler N., Rotter V., Shakked Z. & Haran T. E. (2017), Proceedings of the National Academy of Sciences of the United States of America. 114, 40, p. 10624-10629
  • A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10

    Authors: Haase G., Gavert N., Brabletz T. & Ben-Ze'ev A. (2017), Oncogene. 36, 11, p. 1597-1606
  • Real Time Laser Speckle Imaging Monitoring Vascular Targeted Photodynamic Therapy

  • A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development

    Authors: Boege Y., Malehmir M., Healy M. E., Bettermann K., Lorentzen A., Vucur M., Ahuja A. K., Bohm F., Mertens J. C., Shimizu Y., Frick L., Remouchamps C., Mutreja K., Kaehne T., Sundaravinayagam D., Wolf M. J., Rehrauer H., Koppe C., Speicher T., Padrissa-Altes S., Maire R., Schattenberg J. R. M., Jeong J., Liu L., Zwirner S., Boger R., Hueser N., Davis R. J., Mullhaupt B., Moch H., Schulze-Bergkamen H., Clavien P., Werner S., Borsig L., Luther S. A., Jost P. J., Weinlich R., Unger K., Behrens A., Hillert L., Dillon C., Di Virgilio V. M., Wallach D., Dejardin E., Zender L., Naumann M., Walczak H., Green D. R., Lopes M., Lavrik I., Luedde T., Heikenwalder M. & Weber A. (2017), Cancer Cell. 32, 3, p. 342-+
  • p53 is essential for DNA methylation homeostasis in naive embryonic stem cells, and its loss promotes clonal heterogeneity

    Authors: Tovy A., Spiro A., McCarthy R., Shipony Z., Aylon Y., Allton K., Ainbinder E., Furth N., Tanay A., Barton M. & Oren M. (2017), GENES & DEVELOPMENT. 31, 10, p. 959-972
  • Light-Stimulated Generation of Free Radicals by Quinones-Chelators

    Authors: Markova I. D., Polyakov N. E., Selyutina O. Y., Fedenok L. G., Fedotov K. Y., Slepneva I. A., Leshina T. V., Pokrovsky A. G., Vasilieva N. V. & Weiner L. M. (2017), Zeitschrift Fur Physikalische Chemie-International Journal Of Research In Physical Chemistry & Chemical Physics. 231, 2, p. 369-389
  • CD84 mediates CLL-microenvironment interactions

    Authors: Marom A., Barak A. F., Kramer M. P., Lewinsky H., Binsky-Ehrenreich I., Cohen S., Tsitsou-Kampeli A., Kalchenko V. (., Kuznetsov Y., Mirkin V., Dezorella N., Shapiro M., Schwartzberg P. L., Cohen Y., Shvidel L., Haran M., Becker Herman H. S., Herishanu Y. & Shachar I. (2017), Oncogene. 36, 5, p. 628-638
  • Contrast enhanced ultrasound imaging can predict vascular-targeted photodynamic therapy induced tumor necrosis in small animals

    Authors: Comelis F. H., Kim K., Durack J. C., Jebiwott S., Scherz A., Srimathveeravalli G. & Coleman J. A. (2017), Photodiagnosis and Photodynamic Therapy. 20, p. 165-168
  • Non-canonical NF kappa B mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB: p50 NF kappa B pathway

    Authors: Roy P., Mukherjee T., Chatterjee B., Vijayaragavan B., Banoth B. & Basak S. (2017), Oncogene. 36, 10, p. 1417-1429
  • Matrix Mechanosensing: From Scaling Concepts in 'Omics Data to Mechanisms in the Nucleus, Regeneration, and Cancer

    Authors: Discher D. E., Smith L., Cho S., Colasurdo M., Garcia A. J. & Safran S. (2017), Annual Review of Biophysics. 46, p. 295-315
  • The short and the long: non-coding RNAs and growth factors in cancer progression

    Authors: Sas-Chen A., Srivastava S. & Yarden Y. (2017), Biochemical Society Transactions. 45, p. 51-64
  • p53 on the crossroad between regeneration and cancer

    Authors: Charni M., Aloni-Grinstein R., Molchadsky A. & Rotter V. (2017), Cell Death and Differentiation. 24, 1, p. 8-14
  • The nonreceptor tyrosine kinase c-Src attenuates SCF(beta-TrCP) E3-ligase activity abrogating Taz proteasomal degradation

    Authors: Shanzer M., Adler J., Ricardo Lax L. I., Reuven N. & Shaul Y. (2017), Proceedings of the National Academy of Sciences of the United States of America. 114, 7, p. 1678-1683
  • Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues

    Authors: Chai C., Rivkin M., Berkovits L., Simerzin A., Zorde-Khvalevsky E., Rosenberg N., Klein S., Yaish D., Durst R., Shpitzen S., Udi S., Tam J., Heeren J., Worthmann A., Schramm C., Kluwe J., Ravid R., Hornstein E., Giladi H. & Galun E. (2017), Gastroenterology. 153, 5, p. 1404-1415
  • Can immunotherapy treat neurodegeneration?

    Authors: Schwartz M. (2017), Science. 357, 6348, p. 254-255
  • From Prokaryotes to Cancer: Glutamine Flux in Multicellular Units

    Authors: Erez A. & Kolodkin-Gal I. (2017), Trends in Endocrinology and Metabolism. 28, 9, p. 637-644
  • Tumor Suppression by p53: Bring in the Hippo!

    Authors: Aylon Y. & Oren M. (2017), Cancer Cell. 32, 4, p. 397-399
  • p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling

    Authors: Yosef R., Pilpel N., Papismadov N., Gal H., Ovadya Y., Vadai E., Miller S., Porat Z., Ben-Dor S. & Krizhanovsky V. (2017), EMBO Journal. 36, 15, p. 2280-2295
  • Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells

    Authors: Panayotopoulou E. G., Muller A., Boerries M., Busch H., Hu G. & Lev S. (2017), Oncotarget. 8, 28, p. 45088-45104
  • Newly Formed Endothelial Cells Regulate Myeloid Cell Activity Following Spinal Cord Injury via Expression of CD200 Ligand

    Authors: Cohen M., Ben-Yehuda H., Porat Z., Raposo C., Gordon S. & Schwartz M. (2017), Journal of Neuroscience. 37, 4, p. 972-985
  • Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors

    Authors: Shetzer Y., Napchan Y., Kaufman T., Molchadsky A., Tal P., Goldfinger N. & Rotter V. (2017), International Journal of Cancer. 140, 6, p. 1364-1369
  • The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element

    Authors: Marin-Bejar O., Mas A. M., Gonzalez J., Martinez D., Athie A., Morales X., Galduroz M., Raimondi I., Grossi E., Guo S., Rouzaut A., Ulitsky I. & Huarte M. (2017), GENOME BIOLOGY. 18, 202
  • Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

    Authors: Rednam S. P., Erez A., Druker H., Janeway K. A., Kamihara J., Kohlmann W. K., Nathanson K. L., States L. J., Tomlinson G. E., Villani A., Voss S. D., Schiffman J. D. & Wasserman J. D. (2017), Clinical Cancer Research. 23, 12, p. E68-E75
  • Integrating multiple fitting regression and Bayes decision for cancer diagnosis with transcriptomic data from tumor-educated blood platelets

    Authors: Huang G., Yuan M., Chen M., Li L., You W., Li H., Cai J. J. & Ji G. (2017), Analyst. 142, 19, p. 3588-3597
  • Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs

    Authors: Yogev O., Henderson S., Hayes M. J., Marelli S. S., Ofir Birin B. Y., Regev-Rudzki N., Herrero J. & Enver T. (2017), PLoS Pathogens. 13, 8, e1006524
  • The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway

    Authors: Furth N. & Aylon Y. (2017), Cell Death and Differentiation. 24, 9, p. 1488-1501
  • The microbiome in anti-cancer therapy

    Authors: Bashiardes S., Tuganbaev T., Federici S. & Elinav E. (2017), Seminars in Immunology. 32, C, SI, p. 74-81
  • FXYD5 (dysadherin) may mediate metastatic progression through regulation of the beta-Na+-K+-ATPase subunit in the 4T1 mouse breast cancer model

    Authors: Lubarski-Gotliv I., Dey K., Kuznetsov Y., Kalchenco V., Asher C. & Garty H. (2017), American Journal Of Physiology-Cell Physiology. 313, 1, p. C108-C117
  • Classification of High-Grade Glioma into Tumor and Nontumor Components Using Support Vector Machine

    Authors: Blumenthal D. T., Artzi M., Liberman G., Bokstein F., Aizenstein O. & Ben Bashat B. D. (2017), American Journal of Neuroradiology. 38, 5, p. 908-914
  • Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival

    Authors: Bublik D. R., Bursac S., Sheffer M., Orsolic I., Shalit T., Tarcic O., Kotler E., Mouhadeb O., Hoffman Y., Fuchs G., Levin Y., Volarevic S. & Oren M. (2017), Proceedings of the National Academy of Sciences of the United States of America. 114, 4, p. E496-E505
  • McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences

    Authors: Tickotsky N., Sagiv T., Prilusky J., Shifrut E. & Friedman N. (2017), Bioinformatics. 33, 18, p. 2924-2929
  • SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress

    Authors: Zipin-Roitman A., Aqaqe N., Yassin M., Biechonski S., Amar M., van Delft D. M. F., Gan O. I., McDermott S. P., Buzina A., Ketela T., Shlush L. I., Xie S., Voisin V., Moffat J., Minden M. D., Dick J. E. & Milyavsky M. (2017), Oncotarget. 8, 10, p. 16712-16727
  • Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1

    Authors: Evans D. G. R., Salvador H., Chang V. Y., Erez A., Voss S. D., Schneider K. W., Scott H. S., Plon S. E. & Tabori U. (2017), Clinical Cancer Research. 23, 12, p. E46-E53
  • Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses

    Authors: Lavin Y., Kobayashi S., Leader A., Amir E. D., Elefant N., Bigenwald C., Remark R., Sweeney R., Becker C. D., Levine J. H., Meinhof K., Chow A., Kim-Shulze S., Wolf A., Medaglia C., Li H., Rytlewski J. A., Emerson R. O., Solovyov A., Greenbaum B. D., Sanders C., Vignali M., Beasley M. B., Flores R., Gnjatic S., Pe'er D., Rahman A., Amit I. & Merad M. (2017), Cell. 169, 4, p. 750-765
  • Pyruvate dehydrogenase has a major role in mast cell function, and its activity is regulated by mitochondrial microphthalmia transcription factor

    Authors: Sharkia I., Erlich T. H., Landolina N., Assayag M., Motzik A., Rachmin I., Kay G., Porat Z., Tshori S., Berkman N., Levi-Schaffer F. & Razin E. (2017), Journal of Allergy and Clinical Immunology. 140, 1, p. 204-+
  • p53-dependent programmed necrosis controls germ cell homeostasis during spermatogenesis

    Authors: Napoletano F., Gibert B., Yacobi-Sharon K., Vincent S., Favrot C., Mehlen P., Girard V., Tell M., Chatelain G., Walter L., Arama E. & Mollereau B. (2017), PLoS Genetics. 13, 9, e1007024
  • Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells

    Authors: Arafeh R., Flores K., Keren-Paz A., Maik-Rachline G., Gutkind N., Rosenberg S., Seger R. & Samuels Y. (2017), Scientific Reports. 7, 16345
  • Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases

    Authors: Rachman-Tzemah C., Zaffryar-Eilot S., Grossman M., Ribero D., Timaner M., Maki J. M., Myllyharju J., Bertolini F., Hershkovitz D., Sagi I., Hasson P. & Shaked Y. (2017), Cell Reports. 19, 4, p. 774-784
  • miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis

    Authors: Kfir-Erenfeld S., Haggiag N., Biton M., Stepensky P., Assayag-Asherie N. & Yefenof E. (2017), Oncotarget. 8, 1, p. 472-489
  • Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome

    Authors: Schwartzman O., Savino A. M., Gombert M., Palmi C., Cario G., Schrappe M., Eckert C., von Stackelberg A., Huang J., Hameiri-Grossman M., Avigad S., te Kronnie G., Geron I., Birger Y., Rein A., Zarfati G., Fischer U., Mukamel Z., Stanulla M., Biondi A., Cazzaniga G., Vetere A., Wagner B. K., Chen Z., Chen S., Tanay A., Borkhardt A. & Izraeli S. (2017), Proceedings Of The National Academy Of Sciences Of The United States Of America-Physical Sciences. 114, 20, p. E4030-E4039
  • Synonymous Somatic Variants in Human Cancer Are Not Infamous: A Plea for Full Disclosure in Databases and Publications

    Authors: Soussi T., Taschner P. E. M. & Samuels Y. (2017), Human Mutation. 38, 4, p. 339-342
  • Jaspine B induces nonapoptotic cell death in gastric cancer cells independently of its inhibition of ceramide synthase

    Authors: Cingolani F., Simbari F., Luis Abad A. J., Casasampere M., Fabrias G., Futerman A. H. & Casas J. (2017), Journal of Lipid Research. 58, 8, p. 1500-1513
  • Tracing the origins of relapse in acute myeloid leukaemia to stem cells

    Authors: Shlush L. I., Mitchell A., Heisler L., Abelson S., Ng S. W. K., Trotman-Grant A., Medeiros J. J. F., Rao-Bhatia A., Jaciw-Zurakowsky I., Marke R., McLeod J. L., Doedens M., Bader G., Voisin V., Xu C., McPherson J. D., Hudson T. J., Wang J. C. Y., Minden M. D. & Dick J. E. (2017), Nature. 547, 7661, p. 104-108
  • Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy

    Authors: Kim K., Zhang H., La Rosa R. S., Jebiwott S., Desai P., Kimm S., Scherz A., O'Donoghue J. A., Weber W. A. & Coleman J. A. (2017), Clinical Cancer Research. 23, 13, p. 3343-3351
  • Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40

    Authors: Levin N., Pato A., Cafri G., Eisenberg G., Peretz T., Margalit A., Lotem M. & Gross G. (2017), Journal of Immunotherapy. 40, 2, p. 39-50
  • Post-translational regulation of p53 function through 20S proteasome-mediated cleavage

    Authors: Solomon H., Brauning B., Fainer I., Ben-Nissan G., Rabani S., Goldfinger N., Moscovitz O., Shakked Z., Rotter V. & Sharon M. (2017), Cell Death and Differentiation. 24, 12, p. 2187-2198
  • Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease

    Authors: Golan T., Stossel C., Schvimer M., Atias D., Halperin S., Buzhor E., Raitses Gurevich G. M., Cohen K., Pri-Chen S., Wilson J., Denroche R. E., Lungu I., Bartlett J. M. S., Mbabaali F., Yarden Y., Nataraj N. B., Gallinger S. & Berger R. (2017), Oncotarget. 8, 25, p. 40778-40790
  • Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders

    Authors: Evans D. G. R., Salvador H., Chang V. Y., Erez A., Voss S. D., Druker H., Scott H. S. & Tabori U. (2017), Clinical Cancer Research. 23, 12, p. E54-E61
  • The cancer paradigms of mammalian regeneration: can mammals regenerate as amphibians?

    Authors: Tzahor E. & Sarig R. (2017), Carcinogenesis. 38, 4, p. 359-366
  • The Leo Sachs' legacy: a pioneer's journey through hematopoiesis

  • Genetic and Functional Analysis of GRIN2A in Tumor Samples

    Authors: Prickett T. D., Gartner J. J. & Samuels Y. (2017),
  • Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression

    Authors: Fiziev P., Akdemir K. C., Miller J. P., Keung E. Z., Samant N. S., Sharma S., Natale C. A., Terranova C. J., Maitituoheti M., Amin S. B., Martinez-Ledesma E., Dhamdhere M., Axelrad J. B., Shah A., Cheng C. S., Mahadeshwar H., Seth S., Barton M. C., Protopopov A., Tsai K. Y., Davies M. A., Garcia B. A., Amit I., Chin L., Ernst J. & Rai K. (2017), Cell Reports. 19, 4, p. 875-889
  • Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function

    Authors: Gropper Y., Feferman T., Shalit T., Salame T. M., Porat Z. & Shakhar G. (2017), Cell Reports. 20, 11, p. 2547-2555
  • Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

    Authors: Vargas F. A., Furness A. J. S., Solomon I., Joshi K., Mekkaoui L., Lesko M. H., Rota E. M., Dahan R., Georgiou A., Sledzinska A., Ben Aissa A. A., Franz D., Sunderland M. W., Wong Y. N. S., Henry J. Y., O'Brien T., Nicol D., Challacombe B., Beers S. A., Turajlic S., Gore M., Larkin J., Swanton C., Chester K. A., Pule M., Ravetch J. V., Marafioti T., Peggs K. S. & Quezada S. A. (2017), Immunity. 46, 4, p. 577-586
  • Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions

    Authors: Porter C. C., Druley T. E., Erez A., Kuiper R. P., Onel K., Schiffman J. D., Schneider K. W., Scollon S. R., Scott H. S., Strong L. C., Walsh M. F. & Nichols K. E. (2017), Clinical Cancer Research. 23, 11, p. E14-E22
  • RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer

    Authors: Tarcic O., Granit R. Z., Pateras I. S., Masury H., Maly B., Zwang Y., Yarden Y., Gorgoulis V. G., Pikarsky E., Ben-Porath I. & Oren M. (2017), Cell Death and Differentiation. 24, 4, p. 694-704
  • Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor Engagement

    Authors: Dahan R. & Ravetch J. V. (2016), Cancer Cell. 30, 3, p. 369-371
  • Wnt signaling in cancer stem cells and colon cancer metastasis.

    Authors: Basu S., Haase G. & Ben-Ze'ev A. (2016), F1000Research. 5
  • MicroRNA-182 targets SMAD7 to potentiate TGF beta-induced epithelial-mesenchymal transition and metastasis of cancer cells

    Authors: Yu J., Lei R., Zhuang X., Li X., Li G., Lev S., Segura M., Zhang X. & Hu G. (2016), Nature Communications. 7
  • p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression

    Authors: Drayman N., Ben-nun-Shaul O., Butin-Israeli V., Srivastava R., Rubinstein A. M., Mock C. S. & Elyada E. (2016), Oncotarget. 7, 33, p. 52643-52660
  • The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders

    Authors: Amitai M., Taler M., Carmel M., Michaelovsky E., Eilat T., Yablonski M., Orpaz N., Chen A., Apter A., Weizman A. & Fennig S. (2016), Journal of Child and Adolescent Psychopharmacology. 26, 8, p. 727-732
  • Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer

    Authors: Weidner P., Soehn M., Gutting T., Friedrich T., Gaiser T., Magdeburg J. & Kienle P. (2016), Oncotarget. 7, 31, p. 50490-50506
  • NKG2D ligands mediate immunosurveillance of senescent cells

    Authors: Sagiv A., Burton D., Moshayev Z., Vadai E., Wensveen F., Ben-Dor S., Golani O., Polic B. & Krizhanovsky V. (2016), AGING-US. 8, 2, p. 328-344
  • Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies

    Authors: Rodgers D. T., Mazagova M., Hampton E. N., Cao Y., Ramadoss N. S., Hardy I. R., Schulman A., Du J., Wang F., Singer O., Ma J., Nunez V., Shen J., Woods A. K., Wright T. M., Schultz P. G., Kim C. H. & Young T. S. (2016), Proceedings of the National Academy of Sciences of the United States of America. 113, 4, p. E459-E468
  • Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis

    Authors: Georgoudaki A., Prokopec K. E., Boura V. F., Hellqvist E., Sohn S., Ostling J., Dahan R., Harris R. A., Rantalainen M., Klevebring D., Sund M., Brage S. E., Fuxe J., Rolny C., Li F., Ravetch J. V. & Karlsson M. C. I. (2016), Cell Reports. 15, 9, p. 2000-2011
  • LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.

    Authors: Sas-Chen A., Aure M. R., Leibovich L., Carvalho S., Enuka Y., Korner C., Polycarpou-Schwarz M., Lavi S., Nevo N., Kuznetsov Y., Yuan J., Azuaje F., Ulitsky I., Diederichs S., Wiemann S., Yakhini Z., Kristensen V. N., Borresen-Dale A. & Yarden Y. (2016), EMBO Molecular Medicine. 8, 9, p. 1052-64
  • The relationship between the nucleolus and cancer: Current evidence and emerging paradigms

    Authors: Orsolic I., Jurada D., Pullen N., Oren M., Eliopoulos A. G. & Volarevic S. (2016), Seminars in Cancer Biology. 37-38, p. 36-50
  • Tumor macrophages are pivotal constructors of tumor collagenous matrix

    Authors: Afik R., Zigmond E., Vugman M., Klepfish M., Shimshoni E., Pasmanik-Chor M., Shenoy A., Bassat E., Halpern Z., Geiger T., Sagi I. & Varol C. (2016), J. Exp. Med. 213, 11
  • The Hippo pathway, p53 and cholesterol.

    Authors: Aylon Y. & Oren M. (2016), Cell cycle (Georgetown, Tex.). 15, 17, p. 2248-55
  • Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL.

    Authors: Yosef R., Pilpel N., Tokarsky-Amiel R., Biran A., Ovadya Y., Cohen S., Vadai E., Dassa L., Shahar E., Condiotti R., Ben-Porath I. & Krizhanovsky V. (2016), Nature Communications. 7, p. 11190, 27048913
  • Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation

    Authors: Shetzer Y., Molchadsky A. & Rotter V. (2016), Cold Spring Harbor perspectives in medicine. 6, 10, p. 2016
  • Prediction of multidimensional drug dose responses based on measurements of drug pairs

    Authors: Zimmer A., Katzir I., Dekel E., Mayo A. E., Alon U., Arcavi I., Challis P., Chambers K. C., Chen T. -., Cowperthwaite P. S., Gal-Yam A., Hosseinzadeh G., Howell D. A., Inserra C., Kankare E., Magnier E. A., Maguire K., Mazzali P. A., McCully C., Milisavljevic D., Smith K. W., Taubenberger S., Valenti S., Wainscoat R. J., Yaron O. & Young D. R. (2016), Proceedings of the National Academy of Sciences of the United States of America. 113, 37, p. 10442-10447
  • FXYD5 Protein Has a Pro-inflammatory Role in Epithelial Cells.

  • Analysis of Subcellular RNA Fractions Revealed a Transcription-Independent Effect of Tumor Necrosis Factor Alpha on Splicing, Mediated by Spt5.

    Authors: Diamant G., Eisenbaum T., Leshkowitz D. & Dikstein R. (2016), Molecular and Cellular Biology. 36, 9, p. 1342-1353
  • Adipose-Induced Retroperitoneal Soft Tissue Sarcoma Tumorigenesis: A Potential Crosstalk between Sarcoma and Fat Cells

    Authors: Loewenstein S., Lubezky N., Nizri E., Zemel M., Levin Y., Savidor A., Sher O., Klausner J. & Lahat G. (2016), Molecular Cancer Research. 14, 12, p. 1254-1265
  • The cybernetics of TNF: Old views and newer ones

  • mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model

    Authors: Sharbi Yunger Y. A., Grees M., Tzehoval E., Utikal J., Umansky V. & Eisenbach L. (2016), OncoImmunology. 5, 6, e1160183
  • Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors

    Authors: Mancini M. & Yarden Y. (2016), SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 50, p. 164-176
  • Interfering with the Dimerization of the ErbB Receptors by Transmembrane Domain-Derived Peptides Inhibits Tumorigenic Growth in Vitro and in Vivo

    Authors: Bublil E. M., Cohen T., Arnusch C. J., Peleg A., Pines G., Lavi S. & Yarden Y. (2016), Biochemistry. 55, 39, p. 5520-5530
  • Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells

    Authors: Grespi F., Landre V., Molchadsky A., Di Daniele D. N., Marsella L. T., Melino G. & Rotter V. (2016), Cell Death & Disease. 7, e2567
  • The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.

    Authors: Aylon Y., Gershoni A., Rotkopf R., Biton I. E., Porat Z., Koh A. P., Sun X., Lee Y., Fiel M., Hoshida Y., Friedman S. L., Johnson R. L. & Oren M. (2016), GENES & DEVELOPMENT. 30, 7, p. 786-97
  • p53 mutations promote proteasomal activity

    Authors: Oren M. & Kotler E. (2016), Nature Cell Biology. 18, 8, p. 833-835
  • Dynamics inside the cancer cell attractor reveal cell heterogeneity, limits of stability, and escape

    Authors: Li Q., Wennborg A., Aurell E., Dekel E., Zou J., Xu Y., Huang S. -. J. & Ernberg I. (2016), Proceedings of the National Academy of Sciences of the United States of America. 113, 10, p. 2672-2677
  • Non-alcoholic fatty liver and the gut microbiota.

    Authors: Bashiardes S., Shapiro H., Rozin S., Shibolet O. & Elinav E. (2016), Molecular Metabolism. 5, 9, p. 782-94
  • Widespread parainflammation in human cancer

    Authors: Aran D., Lasry A., Zinger A., Biton M., Pikarsky E., Hellman A., Butte A. J. & Ben-Neriah Y. (2016), Genome Biology. 17, 145
  • A metabolic link between the urea cycle and cancer cell proliferation

    Authors: Nagamani S. C. S. & Erez A. (2016), Molecular & cellular oncology. 3, 2, 1127314
  • Tumor cell invasion can be blocked by modulators of collagen fibril alignment that control assembly of the extracellular matrix.

    Authors: Grossman M., Ben Chetrit C. N., Zhuravlev A., Afik R., Bassat E., Solomonov I., Yarden Y. & Sagi I. (2016), Cancer Res.. 93, 5, 052206
  • Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine

    Authors: Murray K. S., Winter A. G., Corradi R. B., LaRosa S., Jebiwott S., Somma A., Takaki H., Srimathveeravalli G., Lepherd M., Monette S., Kim K., Scherz A. & Coleman J. A. (2016), Journal of Urology. 196, 1, p. 236-243
  • Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status

    Authors: Pais A. & Degani H. (2016), Frontiers in Oncology. 6, 100
  • Tumor Necrosis Factor Alpha (TNFalpha)

    Authors: Wallach D. & Kovalenko A. (2016), Compendium of Inflammatory Diseases.
  • Overcoming a species-specificity barrier in development of an inhibitory antibody targeting a modulator of tumor stroma.

    Authors: Grossman I., Ilani T., Fleishman S. & Fass D. (2016), Protein engineering, design & selection : PEDS. 29, 4, p. 135-47, 26819240
  • Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation

    Authors: Charni M., Molchadsky A., Goldstein I., Solomon H., Tal P., Goldfinger N., Yang P., Porat Z., Lozano G. & Rotter V. (2016), Cell Death and Differentiation. 23, 2, p. 509-520
  • Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma

    Authors: Inzelberg R., Samuels Y., Azizi E., Qutob N., Inzelberg L., Domany E., Schechtman E. & Friedman E. (2016), Neurology. Genetics. 2, 3, e70
  • The involvement of mutant Rac1 in the formation of invadopodia in cultured melanoma cells

    Authors: Revach O., Winograd-Katz S. E., Samuels Y. & Geiger B. (2016), Experimental Cell Research. 343, 1, p. 82-88
  • The evolution of T-cell depletion in haploidentical stem-cell transplantation

    Authors: Or Geva G. N. & Reisner Y. (2016), British Journal of Haematology. 172, 5, p. 667-684
  • Microglia Replenished OHSC: A Culture System to Study In Vivo Like Adult Microglia

    Authors: Masuch A., van der Pijl d. P. R., Fuener L., Wolf Y., Eggen B., Boddeke E., Biber K., Dalimot J., Bergmueller E., Jung S., Voortman S., Winterhager E., Brandau S., Garbi N., Kurrer M., Eriksson U., Gunzer M. & Hasenberg M. (2016), GLIA. 64, 8, p. 1285-1297
  • Breast MRI: Malignant Cystosarcoma Phyllodes Tumor Exhibits Unique Anisotropic Diffusion

    Authors: Nissan N., Ben-Aharon U. & Yosepovich A. (2016), Israel Medical Association Journal. 18, p. 368-369
  • Optimization of DCE-MRI protocol for the assessment of patients with brain tumors

    Authors: Artzi M., Liberman G., Nadav G., Blumenthal D. T., Bokstein F., Aizenstein O. & Ben Bashat B. D. (2016), Magnetic Resonance Imaging. 34, 9, p. 1242-1247
  • Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.

    Authors: Carvalho S., Levi-Schaffer F., Sela M. & Yarden Y. (2016), British Journal of Pharmacology. 173, 9, p. 1407-24, 26833433
  • Post-translational modification profiling - A novel tool for mapping the protein modification landscape in cancer

    Authors: Eisenberg-Lerner A., Ciechanover A. & Merbl Y. (2016), Experimental Biology and Medicine. 241, 14, p. 1475-1482
  • An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.

    Authors: Carvalho S., Lindzen M., Lauriola M., Shirazi N., Sinha S., Abdul-Hai A., Levanon K., Korach J., Barshack I., Cohen Y., Onn A., Mills G. & Yarden Y. (2016), Oncogene. 35, 4, p. 438, 47
  • Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

    Authors: Lotem M., Merims S., Frank S., Hamburger T., Nissan A., Kadouri L., Cohen J., Straussman R., Eisenberg G., Frankenburg S., Carmon E., Alaiyan B., Shneibaum S., Ayyildiz Z. O., Isbilen M., Senses K. M., Ron I., Steinberg H., Smith Y., Shiloni E., Gure A. O. & Peretz T. (2016), Journal of Immunology Research. 2016, 8121985
  • Genetic and Pharmacological Modulation of Akt1 for Improving Ovarian Graft Revascularization in a Mouse Model

    Authors: Cohen Y., Dafni H., Avni R., Fellus L., Bochner F., Rotkopf R., Raz T., Benjamin L. E., Walsh K. & Neeman M. (2016), Biology of Reproduction. 94, 1, p. 14, 14
  • Extracellular matrix and tissue regeneration

    Authors: Mackiewicz Z., Konttinen Y. T., Kaivosoja E., Stegajev V., Wagner H. D., Levón J. & Tiainen V. M. (2016), Regenerative Medicine - from Protocol to Patient. 3 ed. p. 1-55
  • Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms

    Authors: Zhang L., Cheng Q., Zhang L., Wang Y., Merrill G. F., Ilani T., Fass D., Arner E. S. J. & Zhang J. (2016), Free Radical Biology and Medicine. 99, p. 426-435
  • RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer

    Authors: Tarcic O., Pateras I. S., Cooks T., Shema E., Kanterman J., Ashkenazi H., Boocholez H., Hubert A., Rotkopf R., Baniyash M., Pikarsky E., Gorgoulis V. G. & Oren M. (2016), Cell Reports. 14, 6, p. 1462-1476
  • Targeting mutant p53 for cancer therapy

    Authors: Oren M., Tal P. & Rotter V. (2016), AGING-US. 8, 6, p. 1159-1160
  • Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3

    Authors: Gaborit N., Lindzen M. & Yarden Y. (2016), Human Vaccines & Immunotherapeutics. 12, 3, p. 576-592
  • Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1 alpha for Th17 suppression

    Authors: Chou T., Chuang Y., Hsieh W., Chang P., Liu H., Mo S., Hsu T., Miaw S., Chen R., Kimchi A. & Lai M. (2016), Nature Communications. 7, 11904
  • Genetic manipulation of iron biomineralization enhances MR relaxivity in a ferritin-M6A chimeric complex

    Authors: Radoul M., Lewin L., Cohen B., Oren R., Popov S., Davidov G., Vandsburger M. H., Harmelin A., Bitton R., Greneche J., Neeman M. & Zarivach R. (2016), Scientific Reports. 6, 26550
  • Androgen deprivation therapy potentiates the efficacy of vascular targeted photodynamic therapy of prostate cancer xenografts

    Authors: Kim K., Watson P. A., Jebiwott S., Somma A. J., La Rosa R. S. P., Mehta D., Murray K. S., Lilja H., Ulmert D., Scherz A. & Coleman J. A. (2016), Cancer Research. 76, 2016
  • M-sec regulates polarized secretion of inflammatory endothelial chemokines and facilitates CCL2-mediated lymphocyte transendothelial migration

    Authors: Barzilai S., Blecher-Gonen R., Barnett Itzhaki Z., Zauberman A., Lebel-Haziv Y., Amit I. & Alon R. (2016), Journal of Leukocyte Biology. 99, 6, p. 1045-1055
  • Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy

    Authors: Oren R., Addadi Y., Haziza L. N., Dafni H., Rotkopf R., Meir G., Fishman A. & Neeman M. (2016), International Journal of Cancer. 139, 8, p. 1788-1798
  • A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors

    Authors: Gelfo V., Rodia M. T., Pucci M., Dall'Ora M., Santi S., Solmi R., Roth L., Lindzen M., Bonafe M., Bertotti A., Caramelli E., Lollini P., Trusolino L., Yarden Y., D'Uva G. & Lauriola M. (2016), Oncotarget. 7, 44, p. 72167-72183
  • Mutational scanning reveals the determinants of protein insertion and association energetics in the plasma membrane.

    Authors: Assaf E., Weinstein J., Biran I., Fridman Y., Bibi E. & Fleishman S. (2016), eLife. 5
  • Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor

    Authors: Aghajanian H., Cho Y. K., Manderfield L. J., Herling M. R., Gupta M., Ho V. C., Li L., Degenhardt K., Aharonov A., Tzahor E. & Epstein J. A. (2016), Nature Communications. 7, 12038
  • MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer

    Authors: Donzelli S., Cioce M., Muti P., Strano S., Yarden Y. & Blandino G. (2016), SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 50, p. 133-142
  • A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1

    Authors: Hollander D., Donyo M., Atias N., Mekahel K., Melamed Z., Yannai S., Lev-Maor G., Shilo A., Schwartz S., Barshack I., Sharan R. & Ast G. (2016), Genome Research. 26, p. 541-553
  • Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens

    Authors: Kalaora S., Barnea E., Merhavi-Shoham E., Qutob N., Teer J. K., Shimony N., Schachter J., Rosenberg S. A., Besser M. J., Admon A. & Samuels Y. (2016), Oncotarget. 7, 5, p. 5110-5117
  • The Anticancer Activity of Organotelluranes: Potential Role in Integrin Inactivation

    Authors: Silberman A., Kalechman Y., Hirsch S., Erlich Z., Sredni B. & Albeck A. (2016), ChemBioChem. 17, 10, p. 918-927
  • Can diffusion tensor anisotropy indices assist in breast cancer detection?

    Authors: Furman-Haran E., Grobgeld D., Nissan N., Shapiro-Feinberg M. & Degani H. (2016), Journal of Magnetic Resonance Imaging. 44, 6, p. 1624-1632
  • Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides

    Authors: Tal P., Eizenberger S., Cohen E., Goldfinger N., Pietrokovski S., Oren M. & Rotter V. (2016), Oncotarget. 7, 11, p. 11817-11837
  • Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell Therapy

    Authors: Gross G. & Eshhar Z. (2016), Annual Review of Pharmacology and Toxicology. p. 59-+
  • Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.

    Authors: Yaeger R., Shah M. A., Miller V. A., Kelsen J. R., Wang K., Heins Z. J., Ross J. S., He Y., Sanford E., Yantiss R. K., Balasubramanian S., Stephens P. J., Schultz N., Oren M., Tang L. & Kelsen D. (2016), Gastroenterology. 151, 2, p. 278-287.e6
  • Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery

    Authors: Stock K., Estrada M. F., Vidic S., Gjerde K., Rudisch A., Santo V. E., Barbier M., Blom S., Arundkar S. C., Selvam I., Osswald A., Stein Y., Gruenewald S., Brito C., van Weerden W. W., Rotter V., Boghaert E., Oren M., Sommergruber W., Chong Y., de Hoogt H. R. & Graeser R. (2016), Scientific Reports. 6, 28951
  • Role of the microbiome in non-gastrointestinal cancers.

    Authors: Pevsner-Fischer M., Tuganbaev T., Meijer M., Zhang S., Zeng Z., Chen M. & Elinav E. (2016), World Journal of Clinical Oncology. 7, 2, p. 200-13, 27081642
  • Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI

    Authors: Artzi M., Liberman G., Nadav G., Blumenthal D. T., Bokstein F., Aizenstein O. & Ben Bashat D. (2016), Journal of Neuro-Oncology. 127, 3, p. 515-524
  • Vascular-Targeted Photodynamic Therapy in Prostate Cancer: From Bench to Clinic

    Authors: Scherz A., Salomon Y., Lindner U. & Coleman J. (2016),
  • HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune Microenvironment

    Authors: Zigler M., Shir A., Joubran S., Sagalov A., Edinger N., Lau J., Yu S., Mizraji G., Globerson Levin A., Sliwkowski M. X. & Levitzki A. (2016), Cancer immunology research. 4, 8, p. 688-697
  • The tumor as an organ: comprehensive spatial and temporal modeling of the tumor and its microenvironment.

    Authors: Bloch N. & Harel D. (2016), BMC Bioinformatics. 17, 1, p. 317
  • Parkin Somatic Mutations Link Melanoma and Parkinson's Disease

    Authors: Levin L., Srour S., Gartner J., Kapitansky O., Qutob N., Dror S., Golan T., Dayan R., Brener R., Ziv T., Khaled M., Schueler-Furman O., Samuels Y. & Levy C. (2016), Journal of Genetics and Genomics. 43, 6, p. 369-379
  • Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer

    Authors: Dadiani M., Ben-Moshe N. B., Paluch-Shimon S., Perry G., Balint N., Marin I., Pavlovski A., Morzaev D., Kahana-Edwin S., Yosepovich A., Gal-Yam E. N., Berger R., Barshack I., Domany E. & Kaufman B. (2016), Clinical Cancer Research. 22, 14, p. 3651-3662
  • A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells

    Authors: Volovitz I., Shapira N., Ezer H., Gafni A., Lustgarten M., Alter T., Ben-Horin I., Barzilai O., Shahar T., Kanner A., Fried I., Veshchev I., Grossman R. & Ram Z. (2016), BMC Neuroscience. 17, 30
  • Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations

    Authors: Cooper I., Fridkin M. & Shechter Y. (2016), PLoS One. 11, 7, e0158352
  • Increased number of volatile organic compounds over malignant glottic lesions.

    Authors: Shoffel-Havakuk H., Frumin I., Lahav Y., Haviv L., Sobel N. & Halperin D. (2016), The Laryngoscope. 126, 7, p. 1606-11, 26490745
  • Cellular heterogeneity mediates inherent sensitivity-specificity tradeoff in cancer targeting by synthetic circuits.

    Authors: Morel M., Shtrahman R., Rotter V., Nissim L. & Bar-Ziv R. H. (2016), Proceedings of the National Academy of Sciences of the United States of America. 113, 29, p. 8133-8
  • Multimodal Correlative Preclinical Whole Body Imaging and Segmentation

    Authors: Akselrod-Ballin A., Dafni H., Addadi Y., Biton I., Avni R., Brenner Y. & Neeman M. (2016), Scientific Reports. 6, 27940
  • The Wnt target gene L1 in colon cancer invasion and metastasis

    Authors: Haase G., Gavert N., Brabletz T. & Ben-Ze'ev A. (2016), Cancers. 8, 5, 27187476
  • The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors

    Authors: Schneider M. R. & Yarden Y. (2016), Oncogene. 35, 23, p. 2949-2960
  • Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements

    Authors: Falvo E., Tremante E., Arcovito A., Papi M., Elad N., Boffi A., Morea V., Conti G., Toffoli G., Fracasso G., Giacomini P. & Ceci P. (2016), Biomacromolecules. 17, 2, p. 514-522
  • The ERK cascade inhibitors: Towards overcoming resistance

    Authors: Maik-Rachline G. & Seger R. (2016), Drug Resistance Updates. 25, p. 1-12
  • A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study

    Authors: Assi N., Fages A., Vineis P., Chadeau-Hyam M., Stepien M., Duarte-Salles T., Byrnes G., Boumaza H., Knueppel S., Kuehn T., Palli D., Bamia C., Boshuizen H., Bonet C., Overvad K., Johansson M., Travis R., Gunter M. J., Lund E., Dossus L., Elena-Herrmann B., Riboli E., Jenab M., Viallon V. & Ferrari P. (2015), Mutagenesis. 30, 6, p. 743-753
  • Examination of HER3 targeting in cancer using monoclonal antibodies

    Authors: Gaborit N., Abdul-Hai A., Mancini M., Lindzen M., Lavi S., Leitner O., Mounier L., Chentouf M., Dunoyer S., Ghosh M., Larbouret C., Chardes T., Bazin H., Pelegrine A., Sela M. & Yarden Y. (2015), Proceedings of the National Academy of Sciences of the United States of America. 112, 3, p. 839-844
  • Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation

    Authors: Stoler-Barak L., Petrovich E., Aychek T., Gurevich I., Tal O., Hatzav M., Ilan N., Feigelson S., Shakhar G., Vlodavsky I. & Alon R. (2015), FASEB Journal. 29, 5, p. 2010-2021
  • AML evolution from preleukemia to leukemia and relapse.

    Authors: Shlush L. I. & Mitchell A. (2015), Best practice & research. Clinical haematology. 28, 2-3, p. 81-9
  • Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia.

    Authors: Dezorella N. (2015), Cytometry. Part B, Clinical cytometry.
  • Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth

    Authors: Harel S., Ben-Moshe N., Aylon Y., Bublik D., Moskovits N., Toperoff G., Azaiza D., Biagoni F., Fuchs G., Wilder S., Hellman A., Blandino G., Domany E. & Oren M. (2015), Cell Death and Differentiation. 22, p. 1328-1340
  • Fc gamma Rs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

    Authors: Dahan R., Sega E., Engelhardt J., Selby M., Korman A. J. & Ravetch J. V. (2015), Cancer Cell. 28, 3, p. 285-295
  • In the Hunt for Therapeutic Targets: Mimicking the Growth, Metastasis, and Stromal Associations of Early-Stage Lung Cancer Using a Novel Orthotopic Animal Model

    Authors: Weiss I. D., Ella E., Dominsky O., Smith Y., Abraham M., Wald H., Shlomai Z., Zamir G., Feigelson S., Shezen E., Bar-Shai A., Alon R., Izhar U., Peled A., Shapira O. M. & Wald O. (2015), Journal of Thoracic Oncology. 10, 1, p. 46-58
  • Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells

    Authors: Kozela E., Juknat A., Kaushansky N., Ben-Nun A., Coppola G. & Vogel Z. (2015), Journal of Neuroinflammation. 12, 52
  • An Interactive Tool for Animating Biology, and Its Use in Spatial and Temporal Modeling of a Cancerous Tumor and Its Microenvironment

    Authors: Bloch N., Weiss G., Szekely S. & Harel D. (2015), PLoS One. 10, 7, e0133484
  • Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: Implications for the treatment of human inflammatory bowel disease

    Authors: Shor D. B., Bashi T., Lachnish J., Fridkin M., Bizzaro G., Barshak I., Blank M. & Shoenfeld Y. (2015), Journal of Autoimmunity. 56, p. 111-117
  • Erratum: A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism (vol 24, pg 242, 2013)

    Authors: Pribluda A., Elyada E., Wiener Z., Hamza H., Goldstein R. E., Biton M., Burstain I., Morgenstern Y., Brachya G., Billauer H., Biton S., Snir-Alkalay I., Vucic D., Schlereth K., Mernberger M., Stiewe T., Oren M., Alitalo K., Pikarsky E. & Ben-Neriah Y. (2015),
  • Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk.

    Authors: Sevilya Z., Leitner Dagan Y., Pinchev M., Kremer R., Elinger D., Lejbkowicz F., Rennert H. S., Freedman L. S., Rennert G., Paz-Elizur T. & Livneh Z. (2015), Carcinogenesis. 36, 9, p. 982-991
  • Quantitative computerized western blotting in detail

    Authors: Talmi-Frank D., Jaffe C. L. & Baneth G. (2015),
  • LPS-mediated septic shock is augmented in ceramide synthase 2 null mice due to elevated activity of TNF alpha-converting enzyme

    Authors: Ali M., Saroha A., Pewzner-Jung Y. & Futerman A. H. (2015), FEBS Letters. 589, 17, p. 2213-2217
  • The functional relevance of somatic synonymous mutations in melanoma and other cancers

    Authors: Gotea V., Gartner J. J., Qutob N., Elnitski L. & Samuels Y. (2015), Pigment Cell and Melanoma Research. 28, 6, p. 673-684
  • Next generation HLA-haploidentical HSCT

    Authors: Martelli M., Ianni M., Ruggeri L., Falzetti F., Carotti A., Reisner Y. & Velardi A. (2015), Bone Marrow Transplantation. 50, p. S63-S66
  • Hyperpolarized NMR of plant and cancer cell extracts at natural abundance

    Authors: Dumez J., Milani J., Vuichoud B., Bornet A., Lalande-Martin J., Tea I., Yon M., Maucourt M., Deborde C., Moing A., Frydman L., Bodenhausen G., Jannin S. & Giraudeau P. (2015), Analyst. 140, 17, p. 5860-5863
  • Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis

    Authors: Rabinovich S., Adler L., Yizhak K., Sarver A., Silberman A., Agron S., Stettner N., Sun Q., Brandis A., Helbling D., Korman S., Itzkovitz S., Dimmock D., Ulitsky I., Nagamani S. C. S., Ruppin E. & Erez A. (2015), Nature. 527, 7578, p. 379-383
  • Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation

    Authors: Kim H., Frederick D., Levesque M., Cooper Z., Feng Y., Krepler C., Brill L., Samuels Y., Hayward N., Perlina A., Piris A., Zhang T., Halaban R., Herlyn M., Brown K., Wargo J., Dummer R., Flaherty K. & Ronai Z. (2015), Cell Reports. 11, 9, p. 1458-1473
  • Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer

    Authors: Mancini M., Gaborit N., Lindzen M., Salame T. M., Dall'Ora M., Sevilla-Sharon M., Abdul-Hai A., Downward J. & Yarden Y. (2015), Science Signaling. 8, 379, ra53
  • Genomic Classification of Cutaneous Melanoma

    Authors: & Samuels Y. (2015), Cell. 161, 7, p. 1681-1696
  • Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.

    Authors: Shapiro B., Tocci P., Haase G., Gavert N. & Ben-Ze'ev A. (2015), Oncotarget. 6, 33, p. 34389-401
  • Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy

    Authors: Golomb L., Sagiv A., Pateras I., Maly A., Krizhanovsky V., Gorgoulis V., Oren M. & Ben-Yehuda A. (2015), Cell Death and Differentiation. 22, 11, p. 1764-1774
  • Messenger RNA encoding constitutively active toll-like receptor 4 enhances effector functions of human T cells.

    Authors: Pato A., Eisenberg G., Machlenkin A., Margalit A., Cafri G., Frankenburg S., Merims S., Peretz T., Lotem M. & Gross G. (2015), Clinical and Experimental Immunology.
  • PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition

    Authors: Verma N., Keinan O., Selitrennik M., Karn T., Filipits M. & Lev S. (2015), Nature Communications. 6, 6064
  • Label-free in vivo molecular imaging of underglycosylated mucin-1 expression in tumour cells

    Authors: Song X., Airan R. D., Arifin D. R., Bar-Shir A., Kadayakkara D. K., Liu G., Gilad A. A., van Zijl Z. P. C. M., McMahon M. T. & Bulte J. W. M. (2015), Nature Communications. 6, 6719
  • Physics of active jamming during collective cellular motion in a monolayer

    Authors: Gov N. (2015), PNAS. 112, 49
  • Mechanical interplay between invadopodia and the nucleus in cultured cancer cells

    Authors: Revach O., Weiner A., Rechav K., Sabanay I., Livne A. & Geiger B. (2015), Scientific Reports. 5, 9466
  • Target discovery for T cell therapy: next steps to advance Immunotherapies

    Authors: Eshhar Z. (2015), Journal for ImmunoTherapy of Cancer. 3, 31
  • TOOKAD (R) Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

    Authors: Azzouzi A., Barret E., Bennet J., Moore C., Taneja S., Muir G., Villers A., Coleman J., Allen C., Scherz A. & Emberton M. (2015), World Journal of Urology. 33, 7, p. 945-953
  • Electron spin resonance microscopic imaging of oxygen concentration in cancer spheroids

    Authors: Hashem M., Weiler-Sagie M., Kuppusamy P., Neufeld G., Neeman M. & Blank A. (2015), Journal of Magnetic Resonance. 256, p. 77-85
  • Aging, clonal hematopoiesis and preleukemia: not just bad luck?

    Authors: Shlush L. I., Zandi S., Itzkovitz S. & Schuh A. C. (2015), International Journal of Hematology. 102, 5, p. 513-522
  • Development of pheochromocytoma in ceramide synthase 2 null mice

    Authors: Park W., Brenner O., Kogot-Levin A., Saada A., Merrill A., Pewzner-Jung Y. & Futerman A. H. (2015), Endocrine-Related Cancer. 22, 4, p. 623-632
  • Runx3 at the interface of immunity, inflammation and cancer

    Authors: Lotem J., Levanon D., Negreanu V., Bauer O., Hantisteanu S., Dicken J. & Groner Y. (2015), Biochimica Et Biophysica Acta-Reviews On Cancer. 1855, 2, p. 131-143
  • P53-dependent non-coding RNA networks in chronic lymphocytic leukemia

    Authors: Oren M. & Arundkar S. C. (2015), Leukemia. 29, 10, p. 2015-2023
  • Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer

    Authors: George B., Horn D., Bayo P., Zaoui K., Flechtenmacher C., Grabe N., Plinkert P., Krizhanovsky V. & Hess J. (2015), Cancer Letters. 358, 2, p. 191-199
  • Dispersal of an ancient retroposon in the TP53 promoter of Bovidae: phylogeny, novel mechanisms, and potential implications for cow milk persistency

    Authors: Dekel Y., Machluf Y., Ben-Dor S., Yifa O., Stoler A., Ben-Shlomo I. & Bercovich D. (2015), BMC Genomics. 16, 53
  • c-Abl forces YAP to switch sides.

    Authors: Keshet R., Reuven N. & Shaul Y. (2015), Molecular & cellular oncology. 2, 3, p. e995006, 27308475
  • From mass cytometry to cancer prognosis

    Authors: Winter D. R., Ledergor G. & Amit I. (2015), Nature Biotechnology. 33, 9
  • Down-regulation of LATS kinases alters p53 to promote cell migration

    Authors: Furth N., Bossel Ben-Moshe B. N., Pozniak Y., Porat Z., Geiger T., Domany E., Aylon Y. & Oren M. (2015), Genes and Development. 29, p. 2325-2330
  • Historic recollections: From polymers and proteins to autoimmunity and cancer.

  • Folic acid-tagged protein nanoemulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumors

    Authors: Loureiro A., Bernardes G. J. L., Shimanovich U., Sarria M. P., Nogueira E., Preto A., Gomes A. C. & Cavaco-Paulo A. (2015), Nanomedicine: Nanotechnology, Biology, and Medicine. 11, 5, p. 1077-1083
  • Metabolic dysregulation in monogenic disorders and cancer - finding method in madness.

    Authors: Erez A. & DeBerardinis R. J. (2015), Nature reviews. Cancer. 15, 7, p. 440-8, 26084394
  • c-Abl antagonizes the YAP oncogenic function

    Authors: Keshet R. D., Adler J., Lax I. R., Shanzer M. H., Porat Z., Reuven N. & Shaul Y. (2015), Cell Death and Differentiation. 22, 6, p. 935-945
  • Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression

    Authors: Shvab A., Haase G., Ben Shmuel S. A., Gavert N., Brabletz T., Dedhar S. & Ben-Ze'ev A. (2015), Oncogene. 35, 5, p. 549-557
  • Overshoot during phenotypic switching of cancer cell populations

    Authors: Sellerio A., Ciusani E., Ben-Moshe N. B., Coco S., Piccinini A., Myers C., Sethna J., Giampietro C., Zapperi S. & La Porta P. C. (2015), Scientific Reports. 5, 15464
  • Modeling the finger instability in an expanding cell monolayer

  • PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop

    Authors: Selitrennik M. & Lev S. (2015), Oncotarget. 6, 26, p. 22214-22226
  • Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy

    Authors: Mahlknecht G., Sela M. & Yarden Y. (2015),
  • The nuclear translocation of ERK1/2 as an anticancer target

    Authors: Plotnikov A., Flores K., Maik-Rachline G., Zehorai E., Kapri-Pardes E., Berti D. A., Hanoch T., Besser M. J. & Seger R. (2015), Nature Communications. 6, 6685
  • Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy

    Authors: Moore C. M., Azzouzi A., Barret E., Villers A., Muir G. H., Barber N. J., Bott S., Trachtenberg J., Arumainayagam N., Gaillac B., Allen C., Schertz A. & Emberton M. (2015), BJU International. 116, 6, p. 888-896
  • Inferring biological tasks using Pareto analysis of high-dimensional data

    Authors: Hart Y., Sheftel H., Hausser J., Szekely P., Ben-Moshe N. B., Korem Y., Tendler A., Mayo A. E. & Alon U. (2015), Nature Methods. 12, 3, p. 233-+
  • Photodynamic Quenched Cathepsin Activity Based Probes for Cancer Detection and Macrophage Targeted Therapy

    Authors: Ben-Nun Y., Merquiol E., Brandis A., Turk B., Scherz A. & Blum G. (2015), Theranostics. 5, 8, p. 847-862
  • Single Exposure to near Roadway Particulate Matter Leads to Confined Inflammatory and Defense Responses: Possible Role of Metals

    Authors: Pardo M., Shafer M. M., Rudich A., Schauer J. & Rudich Y. (2015), Environmental Science & Technology. 49, 14, p. 8777-8785
  • Cancer immunotherapy: More is (much) better

    Authors: Yarden Y. & Sela M. (2015), Clinical Cancer Research. 21, 18, p. 4030-4032
  • Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors

    Authors: Cooper I., Last D., Guez D., Sharabi S., Goldman S. E., Lubitz I., Daniels D., Salomon S., Tamar G., Tamir T., Mardor R., Fridkin M., Shechter Y. & Mardor Y. (2015), Journal of Cerebral Blood Flow and Metabolism. 35, 6, p. 967-976
  • Cardiac glycosides induced toxicity in human cells expressing alpha 1-, alpha 2-, or alpha 3-isoforms of Na-K-ATPase

    Authors: Lev M., Karlish S. & Garty H. (2015), American Journal Of Physiology-Cell Physiology. 309, 2, p. C126-C135
  • The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner

    Authors: Shanzer M. H., Ricardo Lax L. I., Keshet R. D., Reuven N. & Shaul Y. (2015), Oncogene. 34, 32, p. 4190-4198
  • MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression.

  • Laparoscopic versus open liver resection for metastatic colorectal cancer

    Authors: Nachmany I., Pencovich N., Zohar N., Ben-Yehuda A., Binyamin C., Goykhman Y., Lubezky N., Nakache R. & Klausner J. M. (2015), EJSO. 41, 12, p. 1615-1620
  • mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity

    Authors: Cafri G., Sharbi Yunger Y. A., Tzehoval E., Alteber Z., Gross T., Vadai E., Margalit A., Gross G. & Eisenbach L. (2015), Molecular Therapy. 23, 8, p. 1391-1400
  • Haploidentical hematopoietic stem cell transplantation: state of art

    Authors: Reisner Y., Aversa F. & Martelli M. (2015), Bone Marrow Transplantation. 50, p. S1-S5
  • Sonicated Protein Fractions of Mycoplasma hyopneumoniae Induce Inflammatory Responses and Differential Gene Expression in a Murine Alveolar Macrophage Cell Line

    Authors: Damte D., Lee S., Birhanu B. T., Suh J. & Park S. (2015), Journal of Microbiology and Biotechnology. 25, 12, p. 2153-2159
  • The Human Otubain2-Ubiquitin Structure Provides Insights into the Cleavage Specificity of Poly-Ubiquitin-Linkages

    Authors: Altun M., Walter T. S., Kramer H. B., Herr P., Iphoefer A., Bostrom J., David Y., Komsany A., Ternette N., Navon A., Stuart D. I., Ren J. & Kessler B. M. (2015), PLoS One. 10, 1
  • Tumor Suppressor Activity of Klotho in Breast Cancer is Revealed by Structure-function Analysis.

    Authors: Ligumsky H. (2015), Molecular cancer research : MCR.
  • Tumor-specific expression and detection of a CEST reporter gene

    Authors: Minn I., Bar-Shir A., Yarlagadda K., Bulte J. W. M., Fisher P. B., Wang H., Gilad A. A. & Pomper M. G. (2015), Magnetic Resonance in Medicine. 74, 2, p. 544-549
  • EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer

    Authors: Kedmi M., Ben Chetrit C. N., Koerner C., Mancini M., Ben-Moshe N. B., Lauriola M., Lavi S., Biagioni F., Carvalho S., Cohen-Dvashi H., Schmitt F., Wiemann S., Blandino G. & Yarden Y. (2015), Science Signaling. 8, 368, ra29
  • Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant

    Authors: Golani O., Naffar-Abu-Amara S. & Geiger B. (2015), The Journal of Clinical Investigation. 125, 4, p. 1648-1664
  • Modeling and Predicting Optimal Treatment Scheduling Between the Antiangiogenic Drug Sunitinib and Irinotecan in Preclinical Settings

    Authors: Wilson S., Tod M., Ouerdani A., Emde A., Yarden Y., Berkane A. A., Kassour S., Wei M. X., Freyer G., You B., Grenier E. & Ribba B. (2015), CPT: Pharmacometrics and Systems Pharmacology. 4, 12, p. 720-727
  • Tyrosine phosphorylation of WW proteins

    Authors: Reuven N., Shanzer M. & Shaul Y. (2015), Experimental Biology and Medicine. 240, 3, p. 375-382
  • Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma

    Authors: Kurscheid S., Bady P., Sciuscio D., Samarzija I., Shay T., Vassallo I., Criekinge W. V., Daniel R. T., van den Bent d. B. M. J., Marosi C., Weller M., Mason W. P., Domany E., Stupp R., Delorenzi M. & Hegi M. E. (2015), Genome Biology. 16, 16
  • Tumor-Associated and Disease-Associated Autoantibody Repertoires in Healthy Colostrum and Maternal and Newborn Cord Sera

    Authors: Madi A., Bransburg-Zabary S., Maayan-Metzger A., Dar G., Ben-Jacob E. & Cohen I. R. (2015), Journal of Immunology. 194, 11, p. 5272-5281
  • Recurrent inactivating RASA2 mutations in melanoma

    Authors: Arafeh R., Qutob N., Emmanuel R., Keren-Paz A., Madore J., Elkahloun A., Wilmott J. S., Gartner J. J., Di Pizio A., Winograd-Katz S., Sindiri S., Rotkopf R., Dutton-Regester K., Johansson P., Pritchard A. L., Waddell N., Hill V. K., Lin J. C., Hevroni Y., Rosenberg S. A., Khan J., Ben-Dor S., Niv M. Y., Ulitsky I., Mann G. J., Scolyer R. A., Hayward N. K. & Samuels Y. (2015), Nature Genetics. 47, 12, p. 1408-1410
  • The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage

    Authors: Reuven N., Adler J., Porat Z., Polonio-Vallon T., Hofmann T. & Shaul Y. (2015), Journal of Biological Chemistry. 290, 27, p. 16478-16488
  • Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer

    Authors: Ben Chetrit C. N., Chetrit D., Russell R., Koerner C., Mancini M., Abdul-Hai A., Itkin T., Carvalho S., Cohen-Dvashi H., Koestler W. J., Shukla K., Lindzen M., Kedmi M., Lauriola M., Shulman Z., Barr H., Seger D., Ferraro D. A., Pareja F., Gil-Henn H., Alon R., Milanezi F., Symons M., Ben Hamo H. R., Efroni S., Schmitt F., Wiemann S., Caldas C., Ehrlich M. & Yarden Y. (2015), Science Signaling. 8, 360, ra7
  • Collective Cell Motility Promotes Chemotactic Prowess and Resistance to Chemorepulsion

    Authors: Malet-Engra G., Yu W., Oldani A., Rey-Barroso J., Gov N., Scita G. & Dupre L. (2015), Current Biology. 25, 2, p. 242-250
  • Hepatitis B virus induces RNR-R2 expression via DNA damage response activation

    Authors: Ricardo Lax L. I., Ramanan V., Michailidis E., Shamia T., Reuven N., Rice C., Shlomai A. & Shaul Y. (2015), Journal of Hepatology. 63, 4, p. 789-796
  • Extracellular matrix regulation of ErbB3 in a subset of wild-type BRAF/NRAS melanoma

    Authors: Rosenbaum S., Capparelli C., Berman-Booty L., Gaborit N., Zhan T., Davies M., Setiady Y., Yarden Y. & Aplin A. (2015),
  • Pathway-based personalized analysis of breast cancer expression data

    Authors: Livshits A., Git A., Fuks G., Caldas C. & Domany E. (2015), Molecular Oncology. 9, 7, p. 1471-1483
  • Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression

    Authors: Cohen-Dvashi H., Ben Chetrit C. N., Russell R., Carvalho S., Lauriola M., Nisani S., Mancini M., Nataraj N., Kedmi M., Roth L., Koestler W., Zeisel A., Yitzhaky A., Zylberg J., Tarcic G., Eilam R., Wigelman Y., Will R., Lavi S., Porat Z., Wiemann S., Ricardo S., Schmitt F., Caldas C. & Yarden Y. (2015), EMBO Molecular Medicine. 7, 3, p. 299-314
  • p53 orchestrates between normal differentiation and cancer

    Authors: Rivlin N., Koifman G. & Rotter V. (2015), Seminars in Cancer Biology. 32, p. 10-17
  • ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas

    Authors: Capparelli C., Rosenbaum S., Berman-Booty L. D., Salhi A., Gaborit N., Zhan T., Chervoneva I., Roszik J., Woodman S. E., Davies M. A., Setiady Y. Y., Osman I., Yarden Y. & Aplin A. E. (2015), Cancer Research. 75, p. 3554-3567